ÐÏà¡±á>þÿ =?þÿÿÿ:;<ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥ÁÀ ø¿(lbjbjüÊüÊ ?tž ž ÑcQÿÿÿÿÿÿ·z z ÔÔHHHÿÿÿÿ\\\8”,Àô\‚´f$"<$<$<$&ú.”©0Loqqqqqq$$„²Ö†°•H 6Û%@& 6 6•ÔÔ<$<$Ÿª(±>±>±> 6&ÔR<$H<$o±> 6o±>±>Âá³Ù³Üÿ&"³å³ú<$ÿÿÿÿàèÆAYÔÿÿÿÿ38sw2[Ò<‚¥wº†‡99†‡d_z_z\†‡H»z õ13Ì±>ß3¤ƒ4Šõ1õ1õ1••K=fõ1õ1õ1‚ 6 6 6 6ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ†‡õ1õ1õ1õ1õ1õ1õ1õ1õ1z š: ¶¶Òõpro Institutional Review Board INSTRUCTIONS FOR COMPLETING THE CONTINUING REVIEW REQUEST / NOTICE OF STUDY COMPLETION DO NOT COMPLETE THIS FORM IF YOUR STUDY WAS APPROVED FOR EXEMPT REVIEW To notify the IRB of an exempt study closure, e-mail HYPERLINK "mailto:irb@slu.edu" irb@slu.edu. If you have questions regarding this form, please contact the IRB at 314-977-7744 or email HYPERLINK "mailto:irb@slu.edu" irb@slu.edu. A. DETERMINATION OF WHETHER A CONTINUING REVIEW OR NOTICE OF STUDY COMPLETION IS NEEDED Investigators are considered to be conducting human research if they are (i) obtaining data through intervention or interaction with living individuals or (ii) collecting information about individuals or conducting ongoing data analysis of previously approved full board or expedited projects. When all such activities are completed at ¶¶Òõpro, the research no longer requires a continuing review by SLU IRB and a Notice of Study Completion should be submitted. B. FREQUENCY OF REVIEW FOR STUDY CONTINUATION In accordance with federal regulations, the IRB must review human research protocols at least annually, or more frequently at intervals appropriate to the degree of risk and degree of vulnerability of the subject population. In order to determine whether continuance of IRB approval is warranted, it is the investigator’s responsibility to submit the Continuing Review Request form. Materials not received by the due date or incomplete submissions may not be reviewed by the IRB in time to obtain approval. NOTE: The continuation of research after expiration of IRB approval is a violation of federal regulations. If the IRB has not reviewed and approved a research study by the study’s current expiration date, i.e., IRB approval has expired, research activities should stop. No new subjects may be accrued. If the investigator is actively pursuing renewal with the IRB and believes that an over-riding safety concern exists or ethical issue is involved, the investigator must seek IRB permission to continue study procedures for the brief time required to complete the review process. WHAT TO SUBMIT WITH YOUR CONTINUING REVIEW APPLICATION For studies that are open to accrual and those that are closed to accrual but data collection is ongoing or research related interventions remain active, submit an original and two (2) sets of the following materials with your request for continuing review (For expedited studies, submit an original set of applicable documents): Current SLU IRB application and protocol with all current applicable supplemental materials (e.g., recruitment materials, questionnaires) Current sponsor’s protocol (for sponsored studies) For studies that have an Investigator’s Brochure (IB): Please submit the section of the IB that summarizes risks OR the current full IB. (The summary section may be titled “Summary of Data and Guidance for the Investigator”) Last approved (stamped) consent/assent form(s) and HIPAA Authorization Form if applicable For studies that are open to accrual, submit one clean (unstamped) copy of consent/assent document(s) to be stamped upon IRB approval. For studies that are closed to accrual, submit one clean (unstamped) copy of consent/addendum consent only if subjects need to be re-consented. Any changes, updated and/or new study materials should be submitted along with a HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.doc"change-in-protocol form to accompany the continuing review request form Subject Safety information including the most current Serious Adverse Event (SAE) cumulative table and Data safety monitoring reports since the last IRB approval Publications (e.g., manuscripts, abstracts) since the last IRB approval For studies that are permanently closed to accrual and/or research activities are limited to data analysis, submit an original and one (1) set of the following materials with your request for continuing review: Current SLU IRB application/protocol Any changes, updated and/or new study materials should be submitted along with a HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.doc"change-in-protocol form to accompany the continuing review request form. Publications (e.g., manuscripts, abstracts) since the last IRB approval Subject Safety information WHAT TO SUBMIT WITH YOUR NOTICE OF STUDY COMPLETION For studies for which human research activities are completed, submit the notice of study completion form as a final report. Please do not submit these instructions with the form SAINT LOUIS UNIVERSITYIRB #:Institutional Review Board (IRB) Caroline Bldg, Room C110 (314) 977-7744 (314) 977-7730 (fax) CONTINUING REVIEW REQUEST / NOTICE OF STUDY COMPLETION DATE:IRB Approval Expiration Date:Principal Investigator: Phone/Pager: Department: Address: E-Mail: Degree: Contact Person: Phone/Email: Study Title: (If applicable, use the exact title listed in the grant/contract application.) FOR SPONSORED STUDIES ONLY (IRB Fees): FORMCHECKBOX Bill Sponsor - OR - FORMCHECKBOX Bill SLU DepartmentSponsor/CRO Name: Protocol Number: Sponsor/CRO Contact: Address: E-Mail: Phone: SLU Contact Name: SLU Billing Address: E-Mail: Phone: FORMCHECKBOX REQUEST FOR STUDY RE-INITIATION This box is to be checked if IRB approval has expired, and the investigator is requesting re-initiation of the study to resume research activities. Complete all sections for continuing review. FORMCHECKBOX CONTINUING REVIEW REQUEST, Check here if you are requesting continuing review. The following boxes need to be completed for both re-initiation and continuing review requests. FORMCHECKBOX Study has not started but will become active. (Please complete sections A, B, F, G, H) FORMCHECKBOX Study is ACTIVE, Please check the appropriate box below. FORMCHECKBOX Study is open to accrual. Complete all sections for continuing review. FORMCHECKBOX Study is on hold or halted. Complete all sections for continuing review. FORMCHECKBOX Study is permanently closed to accrual. If you checked this box, please answer the questions below and complete all sections for Continuing Review. Have all subjects completed all research related activities/interventions? No FORMCHECKBOX Yes* FORMCHECKBOX Will the research only remain active for long-term follow-up of subjects? No FORMCHECKBOX Yes* FORMCHECKBOX N/A FORMCHECKBOX Are remaining research activities limited to data analysis only? No FORMCHECKBOX Yes* FORMCHECKBOX For IRB office use: * May qualify for expedited review FORMCHECKBOX NOTICE OF STUDY COMPLETION, Check here if your study should be closed. FORMCHECKBOX Research activities are complete. (Complete sections A, B, C, F, H) When all human research procedures (including data analysis) are completed at ¶¶Òõpro, the research no longer requires continuing review by the SLU IRB. For multi-center studies, continuing review of the research by the SLU IRB is not required after all human research activities have been completed at SLU even if (i) interactions or interventions with subjects may be occurring at other study sites, or (ii) data analysis of identifiable private information is ongoing at another central site that collects and analyzes data from all study sites. For multi-center investigator-initiated studies (e.g., SLU Investigator is the head of this multi-center trial and is responsible for reporting to IRB, FDA, and/or other sites), the SLU IRB would require the study to remain open until all sites have completed the research project and data analysis. FORMCHECKBOX Study can be terminated because research activities never started. (Complete section A and section H ONLY) DOCUMENT CHECKLIST FOR ITEMS SUBMITTED Please refer to the Instructions on Page 1 for a list of materials to be submitted with your Request for Continuing review or Notice of Study Completion. Submit all materials to the same IRB office that initially reviewed the study. Submit 1 original plus 2 complete sets for Full Board Studies, or submit 1 original set for Expedited Studies of the continuing review request form (including current supplemental documents): FORMCHECKBOX Current version of IRB Application and Protocol (version date: _____________ )** FORMCHECKBOX Current version of Sponsor’s Protocol, if applicable (version date: _____________ ) FORMCHECKBOX Last approved (stamped) consent/assent form(s) if applicable (version date _____________ ) FORMCHECKBOX Clean (unstamped) copy of consent/assent form(s) if applicable, and indicate # of consent/assent forms below: FORMCHECKBOX Assent Document(s) _____ Number of assent documents submitted FORMCHECKBOX Standard Consent Document(s) _____ Number of consent documents submitted FORMCHECKBOX Addendum Consent Document(s), if applicable (if study is closed to accrual, but subjects are being re-consented) Submit any documents used in lieu of a standard consent document: FORMCHECKBOX Request for Waiver or Alteration of Informed Consent or Written Consent form FORMCHECKBOX HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/consent_recruitment_statement_template.doc"Recruitment statement or letter FORMCHECKBOX HYPERLINK "http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html" \l "46.117"Short form (45CFR46.117(b)2) FORMCHECKBOX Translated consent documents if the study involves subjects whose first language is not English Submit appropriate HIPAA documents, if applicable: FORMCHECKBOX Last approved (stamped) HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_authorization_form.doc"HIPAA Authorization Form (if HIPAA section is not incorporated into consent form) FORMCHECKBOX HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_waiver_alteration.doc"HIPAA Waiver or Alteration of Authorization Form FORMCHECKBOX HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_deidentification_certification_form.doc"HIPAA De-Identification Certification Form If submitting revisions for review with this continuing review request, please submit all revised materials. FORMCHECKBOX HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.doc"Change-in-protocol form FORMCHECKBOX Revised Consent and/or Assent with changes highlighted* FORMCHECKBOX Revised IRB Protocol with changes highlighted** FORMCHECKBOX Supporting documentation (e.g., Sponsor’s amended materials, etc.) *Note: If you are submitting changes to the consent/assent documents, please include the following with your submission: the old IRB approved (stamped) version, the new version with changes highlighted, and 1 original clean new version copy to be stamped. **Note: If you are submitting changes to the protocol, only the new version of the protocol with changes highlighted should be submitted. DO NOT submit the previously approved version. If safety information exists, please submit any new documents since the last continuing review FORMCHECKBOX Serious Adverse Event (SAE) cumulative form – submit the most recent IRB approved copy of the SAE cumulative table. All new SAE submissions should be submitted separately to the IRB. FORMCHECKBOX Data Safety Monitoring Board (DSMB) or medical monitor report- submit copies of Data Safety Monitoring reports received during the last IRB approval period, including copies that may have previously been submitted to the IRB. FORMCHECKBOX Package insert dated: _____________ (Indicate version number or date if available) FORMCHECKBOX Current Investigator’s Brochure (IB) (Submit the section of the IB that summarizes risks OR the current full IB. The summary section may be titled “Summary of Data and Guidance for the Investigator”) Additional information, if appropriate: FORMCHECKBOX Publications/presentations: Attach citations of any presentations or publications that were derived from the study. Cite all authors (do not use ‘et al’). If there have been publications (e.g., manuscripts, abstracts) in the past approval period, please provide a copy of the entire publication. FORMCHECKBOX Provide documentation of IRB approvals from additional institutions if attaining approval from another IRB. (Does not include approval from sites for multi- centered trials) FORMCHECKBOX Attach a copy of any study external audit findings since the last continuing review HYPERLINK "http://www.slu.edu/research/irb/documents/postirbapprovalreporting.doc"(see post approval information sheet) FORMCHECKBOX Other (please describe): A. STUDY STATUS 1. When was the study initially approved by the IRB? (should match date provided in IRB approval letter) 2. What was the last approval date for continuing review? (if this is first continuing review, state N/A) 3. If requesting re-initiation of a study, explain any research activities occurring during lapse in IRB approval. Otherwise, state “Not applicable”. 4. Have research activities started? FORMCHECKBOX No FORMCHECKBOX Yes If no, please explain in the box below (e.g., awaiting funding, lag in subject accrual with reasons for lag included). Also if this study is on hold, please explain what needs to occur before accrual can resume. NOTE: If there is a change in the anticipated completion date (as stated in the approved protocol), submit a revised protocol and HYPERLINK "http://www.slu.edu/research/irb/irb_instruc.html" change-in-protocol form. 5. Have there been any significant amendments or revisions to the protocol during the past approval period? Significant changes include changes in study design or risk level including those that resulted in a change in consent FORMCHECKBOX No FORMCHECKBOX Yes If yes, please briefly summarize the changes below. B. SUBJECT STATUS Does this study only involve research limited to the review of data, documents, records, or specimens (i.e., there are never any interactions with human subjects)? FORMCHECKBOX No (Proceed to question 2) FORMCHECKBOX Yes (Answer questions in the records/specimens accrual table, below) RECORDS/SPECIMENS ACCRUAL TABLE Number of records/specimens approved by the IRB for the study as stated in the current protocol (Section E: Study Design on SLU IRB Application)Total number of items (records or specimens) that have been collected/reviewed to date (total) (Proceed to Question #4) Please refer to the SLU IRB HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/guidelines_subject_accrual.doc"Policy on Subject Accrual for assistance in answering the following: SUBJECTS ACCRUAL TABLE Number of subjects currently approved by the IRB for the study as stated in current protocol (Section E: Study Design on SLU IRB Application)Subject Accrual Totals B1. Total number of subjects that have given consent (verbal or written) to date B2. Total number of subjects that failed screening* (if not applicable, state N/A) B3. Total number of subjects accrued** to dateNumber of Accrued Subjects Withdrawn or Discontinued (If any subjects have withdrawn or discontinued, see question #3, below)* Subjects are screen failures if they signed a consent form and underwent study screening procedures, but participation did not yield evaluable data. **Accrued subjects are those who have given consent and whose participation yields evaluable data. Evaluable data are data that are intended to contribute to generalizable knowledge (i.e., the study goals). FOR MULTI-CENTER STUDIES ONLY – TOTAL STUDY SUBJECT ACCRUAL TABLE Number of subjects approved for accrual in the total study (SLU site plus all other study sites) Total Study Subject Accrual (according to study sponsor) If any of the subjects in 2C (above) were withdrawn or discontinued due to safety or increased risk, please explain. If withdrawn for any other reason than safety or risk issues, state “Not applicable”. To your knowledge, were there any subject complaints about the research? FORMCHECKBOX No FORMCHECKBOX Yes. If yes, please explain below: 5. For studies that are closed to subject accrual, do any subjects need to be re-consented (to inform them about changes to study procedures, study risks, study personnel, etc.)? FORMCHECKBOX No FORMCHECKBOX Yes. If yes, please submit clean copy of consent/addendum consent for IRB review. FORMCHECKBOX Not applicable. This study is open to accrual. C. SUMMARY OF PROGRESS OR FINDINGS: Briefly describe (1 page maximum) the progress of the study to date. If possible, include any observations, results, or findings. For multi-center studies, include progress for the total study (all sites) if available. 2. Publications, Presentations, and Recent Findings: Have there been any submissions for presentation or publications resulting from this study during the last approval period? Please include only copies published/presented from SLU researcher(s). FORMCHECKBOX No FORMCHECKBOX Yes. If yes, please provide a copy of the abstract or manuscript submitted or published. Have there been any recent findings either from this study, or a related study, which would have an effect on subject safety or the risk/benefit sections of the protocol and/or consent document(s)? FORMCHECKBOX No FORMCHECKBOX Yes. If yes, (and the study is ongoing) and a change in protocol form has not been submitted, please update the protocol and/or consent and submit a HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.doc"change in protocol form with explanation and references. SECTIONS D and E APPLY TO BIOMEDICAL AND BEHAVIORAL & SOCIAL SCIENCES STUDIES D. SERIOUS ADVERSE EVENT (SAE) AND UNANTICIPATED PROBLEM (UP) REPORTING Please refer to the SLU IRB HYPERLINK "/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/guidelines_reportable_events.doc"Requirements for Reporting Events Relating to Subject Safety for assistance in answering the following. REPORT FOR THIS SPECIFIC STUDY: Number of unanticipated problems (UP) at SLU sites since last continuing review (for first year studies, since the initial IRB review):Number of SAE reports at SLU sites (sites under direct guidance of SLU investigators) since last continuing review (for first year studies, since the initial IRB review):** **NOTE: The number reported should match the table on any SAE report already submitted to the IRB. If any SAEs have been reported to the IRB since the last continuing review, please attach a current cumulative SAE report to this submission. All new SAEs should be submitted separately to the IRB. E. SAFETY MONITORING 1. Is there a Data Safety Monitoring (DSM) plan for this study? FORMCHECKBOX No FORMCHECKBOX Yes, a copy of the DSM report(s) for the last approval period is attached. FORMCHECKBOX Yes, but a copy of the DSM report(s) for the last approval period is not attached. Please explain: SECTION F APPLIES TO BIOMEDICAL STUDIES ONLY F. FDA REGULATED STUDIES If this is a FOOD and DRUG ADMINISTRATION (FDA) REGULATED STUDY, (e.g., involves DRUGS, DEVICES, BIOLOGICS), answer the following questions. Otherwise skip to section G YESNOHave there been any changes in the FDA status of any drug or device used in the study?Have any of the investigational drugs or devices used in this study received FDA approval?Have any new alternative drugs or devices been approved for treatment of the study condition that may affect subjects willingness to participate? Has there been a change in the standard care that may be considered as an alternative to the investigational drug or device or that would affect the original study design?Is there any new information that might affect the risk/benefit ratio and the willingness of current study subjects to participate or to continue to participate in the research? Does the study include an investigator’s brochure? If yes, what is the current version date:___/___/____ If yes to any of the above questions 1-5, please explain: If yes to any of the above questions 3-5, have current study subjects been notified? Please explain: CONFLICT OF INTEREST Indicate whether you, your spouse or dependent children, or any investigator participating in the study have, or anticipate having, any income from or financial interest in the sponsor of this protocol, the supporting organization, or a company that owns/licenses the technology being studied that may reasonably affect the outcome of the research. Financial Interest includes but is not limited to consulting, speaking or other fees; honoraria; gifts; licensing revenues; other research agreements; equity interests (including stock, stock options, warrants, partnership and other equitable ownership interests). Is the information you previously reported to the Institutional Review Board (IRB) and the Conflict of Interest Committee (COIC) still accurate and complete? FORMCHECKBOX Yes FORMCHECKBOX No For studies where the investigator(s) indicated a potential conflict of interest, does the consent document still provide adequate disclosure? FORMCHECKBOX Yes FORMCHECKBOX No FORMCHECKBOX N/A NOTE: If you responded “NO” to either of the questions above, please provide the following revised materials to the COIC and/or the IRB. Investigator(s) must have: Current, up-to-date HYPERLINK "/research/faculty-resources/research-integrity-safety/conflict-of-interest-coirc.php"Conflict of Interest Disclosure Form on file with the SLU Conflict of Interest Committee (COIC) that describes any financial relationship indicated. This information must be disclosed on the SLU confidential Conflict of Interest Disclosure Form for review by the COIC before accruing research subjects in this study. If your current Disclosure Form does not contain this information, you are required to submit an updated Disclosure Form to the COIC. Financial disclosure statement incorporated into the consent document. Please see Model Consent for suggested language. In signing this form, the INVESTIGATOR certifies that he/she has read the University’s Conflict of Interest Research Policy and has checked the appropriate box above. In addition, the INVESTIGATOR certifies that, to the best of his/her knowledge, no person working on this project at SLU has a conflict of interest or if a conflict of interest does exist, that an appropriate management plan is in place. For questions regarding Conflicts of Interest, consult the HYPERLINK "/general-counsel/compliance/conflict-of-interest.php"Conflict of Interest in Research Policy. H. INVESTIGATOR ASSURANCE AND SIGNATURE Investigator’s Assurance: I certify that the information provided is complete and accurate. As Principal Investigator, I have ultimate responsibility for the conduct of this study, the ethical performance of the project, the protection of the rights and welfare of human subjects and strict adherence to any stipulations designated by the SLU IRB. I agree to comply with all SLU policies and procedures, as well as with all applicable Federal, State and local laws regarding the protection of human subjects in research. ________________________________________________ ______________ Principal Investigator’s Signature Date For IRB Use OnlyContinuing Review_ ____ Approved on an expedited basis under category (ies) __________ IRB#___________________ ____ Approved at the IRB meeting of:_____________ Board #:_____ ____ Continuing Review of Consent Form(s) approved; use only the attached consent form(s) with the updated IRB approval stamp. ____ Re-initiation/Expedited Approval ____ Re-initiation/Full Review/Full Approval at the IRB meeting of:_____________ Period of approval: One year____ or specify period:__________ Study Closure ____IRB Notified of study’s discontinuance/completion Signature of IRB Chairperson or IRB Designee________________________________________________________________ Date:_____/_____/_____ IRB Template Date: 8/1/11 PAGE PAGE 6 Version: 2lmn‰Š‹Ò ( ) * 5 6 7 9 : ‹ Œ • óâÑâÑâÂ°£’£~’q’£dZMZ@hw(bhËzpOJQJ^Jhw(bh`:óOJQJ^Jh¨I6OJQJ^Jhw(bhw(bOJQJ^Jhy'hw(b0JCJaJ'jhy'hw(bOJQJU^J!jhy'hw(bOJQJU^Jhy'hw(bOJQJ^J"h'aÍhïWò5CJOJQJ\^JhïWò5CJOJQJ\^J hZ’5CJOJQJ\^JaJ hïWò5CJOJQJ\^JaJhïWò5OJQJ\^J23SŠ‹Ò: Æ Ç ! ÿ/0-.uvøù„úúúúøúððøøøççøøáøøøøÙøÉ &F Æ „^„gdòAß &Fgdú„h^„h„h^„hgd=.$a$gd=.$a$• – ¶ · ¸ Ã Ä Æ Ç û ! Ì Ø ø Eÿ/0îáÍîÀîá¯¤™¤‚xnxdxdxS¤>x)h`:óhïWòB* CJ OJQJ^JaJ ph€ h=.h=.CJ OJQJ^JaJ h‘~ÄOJQJ^Jh¯{—OJQJ^JhïWòOJQJ^J,h`:óhïWò6B* CJ OJQJ^JaJ ph€hZ’5OJQJ^JhïWò5OJQJ^J hfäh`:óCJ OJQJ^JaJ hw(bhËzp0JCJaJ'j³hw(bhËzpOJQJU^Jhw(bhËzpOJQJ^J!jhw(bhËzpOJQJU^J#-.3UZ_`ÍÔØ 'uv¬¾ÊÑöìÛÍÀ¶À¬À¬ÀŸ¬ŸÀŽ~n`L;!h@W56B*OJQJ^Jph'h‘~ÄhïWò56B*OJQJ^JphhïWòB*OJQJ^Jphh=.hïWò5>*OJQJ^JhËzphËzp5>*OJQJ^J hËzphËzpCJOJQJ^JaJhŠvåhnrOJQJ^JhyEOJQJ^Jh@WOJQJ^JhŠvåhïWòOJQJ^JhŠvåhïWò5OJQJ^J hfähïWòCJ OJQJ^JaJ hïWòOJQJ^Jh42OJQJ^JÑÖï÷û7EŽ§Üôö÷øîÝÌÝ»ª»–»ˆzi[iJ=h†¦hïWòOJQJ^J!h†¦hïWòB*OJQJ^Jphh†¦B*OJQJ^Jph!h†¦hÞëB*OJQJ^JphhÞëB*OJQJ^JphhïWòB*OJQJ^Jph'h‘~ÄhïWò56B*OJQJ^Jph!hVQ56B*OJQJ^Jph!hd…56B*OJQJ^Jph!h@W56B*OJQJ^Jph!h4256B*OJQJ^Jph!h 2»56B*OJQJ^Jphøù*+>T\‚„¶·Ðçìíîûü'(ïÞÐÞÃ¹¬Ÿ’…tgYtHYtHY7H!hy'hÕS‰B*OJQJ^Jph!hy'hÉßB*OJQJ^JphhÕS‰B*OJQJ^Jphhy'hi3ŸOJQJ^J!hy'hïWòB*OJQJ^Jphhy'hnrOJQJ^Jhy'hZ’OJQJ^JhƒjhZ’OJQJ^JhƒjhnrOJQJ^Jh‘~ÄOJQJ^JhƒjhïWòOJQJ^JhÞëB*OJQJ^Jph!hƒjhïWòB*OJQJ^Jph hfähïWòCJOJQJ^JaJ„·˜ò UùAB<‰Ñìí!žïïïïÞÞÞÕÍ¼«š«‘Šgd42„Ð^„Ðgdi3Ÿ &F Æp„^„gdÀI &F Æp„^„gdfä &F Æp„0ý`„0ýgdfä &Fgdú„8^„8gdfä &F Æp„^„gd42 &F Æ „^„gdòAß(*+>@A–—˜ÇäñòëÚÉÚ»ÚªtcRB2Bch@W>*B*OJQJ^JphhPJ¬>*B*OJQJ^Jph!h.DhPJ¬B*OJQJ^Jph!hF£h»Z–B*OJQJ^JphhF£hËzpOJQJ^JhF£hë"¸OJQJ\^JhF£hËzpOJQJ\^Jhy'hïWòOJQJ^J!hy'h±ùB*OJQJ^JphhÕS‰B*OJQJ^Jph!hy'hÕS‰B*OJQJ^Jph!hy'hÉßB*OJQJ^Jph'hy'hÉß6>*B*OJQJ^Jph#$wyŽ˜Ÿ¡«¬ÆÏßäçðû îÝÌ»ª—‡ªveªeªvªeveªXNDhi3ŸOJQJ^JhïWòOJQJ^JhF£h»Z–OJQJ^J!hè8¡hO@LB*OJQJ^Jph!hè8¡hÚ=B*OJQJ^Jphh@W>*B*OJQJ^Jph$hè8¡h»Z–>*B*OJQJ^Jph!hè8¡h»Z–B*OJQJ^Jph!hF£h=.B*OJQJ^Jph!hF£hïWòB*OJQJ^Jph!hF£h»Z–B*OJQJ^Jph!hF£hÚ=B*OJQJ^Jph/8Z[ #$OTUÛ÷%@ABWcmtux{öìâÔÊ¹Ô¬Ôâìâ¢˜¢˜¢‡}oaVL}Bh OJQJ^Jh@WOJQJ^Jh@W5OJQJ^JhºY’hfä5OJQJ^JhºY’h 5OJQJ^JhfäOJQJ^J hfähfäCJ OJQJ^JaJ hŠvåOJQJ^JhoQ®OJQJ^Jhi3ŸhïWò0JCJaJ!jfhª-”OJQJU^Jhª-”OJQJ^Jjhi3ŸOJQJU^JhïWòOJQJ^Jhi3ŸOJQJ^JhÌ:kOJQJ^J{|…¬®ÅÐ<lŽ=>?VW‰ìí öèÚöÌ»ö£ö•‹z•m•öcRBhËzphËzp5>*OJQJ^J hÀI hïWòCJOJQJ^JaJhÀI OJQJ^Jhi3Ÿhfä0JCJaJ!j7hª-”OJQJU^Jhª-”OJQJ^JjhfäOJQJU^JhÌ:kOJQJ^JhfäB*OJQJ^Jph!hÉßh=.B*OJQJ^Jphh=.B*OJQJ^JphhºY’hfä5OJQJ^JhºY’h 5OJQJ^JhfäOJQJ^J !,-6FPžÓÔÕÖ×ôõöðæÜÏÂµ«Â–„€|q]K>- h>x5CJOJQJ\^JaJhïWò5OJQJ\^J#hj8hïWò>*CJOJQJ^JaJ&hj8hïWò5CJOJQJ\^JaJhR ‚hsy¹CJ aJ hïWòhnr#hfä5>*CJOJQJ\^JaJ)hnrhfä5>*CJOJQJ\^JaJhËzpOJQJ^JhƒjhZ’OJQJ^JhƒjhïWòOJQJ^JhƒjhnrOJQJ^JhnrOJQJ^JhïWòOJQJ^Jh=.hïWò5>*OJQJ^JžÔÖ×îõö0?T÷òòåÕ~ååååWkd$$If–P4”fÖ0°ÿ E*Z;ÿÿÿÿÿÿÿÿÿÿÿÿ 6`”Éÿ”´ö•*ööÖÿÿÿÿÿÖÿÿÖÿÿÿÿÿÖÿÿÿÿÿ”´4Ö Paöf4$$„Éÿ&`#$/„´Ifa$ $„Éÿ&`#$/„´IfgdQ $$a$gdÀI >STUVŽ“”™¡¢¬®²³ÉèóìÛìÛìÎº¦˜‹{‹k‹k‹k_{_Q_{Bhs#nhsy¹@ˆúÿOJQJ^Jhsy¹@ˆúÿOJQJ^JaJhsy¹@ˆúÿOJQJ^Jh6ihsy¹5@ˆúÿOJQJ^Jhs#nhsy¹5@ˆúÿOJQJ^Jhsy¹5@ˆúÿOJQJ^Jhsy¹CJOJQJ^JaJ&h©hj85CJOJQJ\^JaJ&h!îh!î5CJOJQJ\^JaJh>x5OJQJ\^J h>x5CJOJQJ\^JaJ&hME&h>x5CJOJQJ\^JaJTUVŽ”²¸¬¬¤””$„'&`#$/„´Ifgdsy¹dœÿgd•{á$ Æ´a$gdí²Gkd£$$If–P4”]Ö°ÿ Z 6`”Éÿ”´ö•*öö;ÖÿÖÿÖÿÖÿ”´4Ö Paöf4ytÿ1\²³ÌÚiYY$„'&`#$/„´Ifgdsy¹•kd$$If–sÖ” Ö0ÿì˜+€_€¬ Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ööÖÿÿÖÿÿÖÿÿÖÿÿ”´4Ö saöpÖÿÌÿÿÿÌÿÿÚÛèòiU8 ÆàÀ!$„'&`#$/„´5$7$8$9DH$Ifgdsy¹ Æ$„'&`#$/„´Ifgdsy¹•kdó$$If–sÖ” Ö0ÿì˜+€_€¬ Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ööÖÿÿÖÿÿÖÿÿÖÿÿ”´4Ö saöpÖÿÌÿÿÿÌÿÿòóüfR:*$„'&`#$/„´Ifgdsy¹ Æ„=$„'&`#$/„´If^„=gdsy¹ Æ$„'&`#$/„´Ifgdsy¹˜kdÌ$$If–s4Ö” Ö0ÿì˜+€_`¬ Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ööÖÿÿÖÿÿÖÿÿÖÿÿ”´4Ö saöf4pÖÿÌÿÿÿÌÿÿ&N>>$„'&`#$/„´Ifgdsy¹°kd¾$$If–s4Ö” ÖFÿÐ ì˜+€C€ ¬ Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ööÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ”´4Ö saöf4pÖÿÌÿÿÿÌÿÿÿÿ$'3‚†‡¡¬®¯°¾¿ÀÖ×åîÛÏÅÏ¶¨’„veXDeXeX'jhq #hq #OJQJU^Jhq #hq #OJQJ^J!jhq #hq #OJQJU^Jh—`h•{áOJQJ\^Jh•{áh•{áOJQJ\^Jhd…5OJQJ^Jh•{á5OJQJ^Jhd…hR ‚5OJQJ^Jh•{á5CJOJQJ^JaJhsy¹OJQJ^Jhsy¹@ˆúÿOJQJ^J$hThsy¹@ˆúÿCJOJQJ^JaJ!hsy¹5@ˆúÿCJOJQJ^JaJ&'ƒ„…xhhh$„'&`#$/„´Ifgdsy¹†kdº $$If–sÖ” Ö0ÿì˜+€_€¬ 6`”'”´Ö0ÿÿÿÿÿÿö,ööÖÿÿÖÿÿÖÿÿÖÿÿ”´4Ö saöpÖÿÿÿÿ…†‡¯üƒ|s $Ifgdq #¤Pgd•{á dˆÿ¤Pgd•{áqkdu $$If–s4Ö”?Öÿ˜+€, 6`”'”´Ö0ÿÿÿÿÿÿö,ööÖÿÖÿÖÿÖÿ”´4Ö saöf4pÖ ÿÿåæçûüý"#9DEXY]ilƒ˜™š›©ëÚÍ¾³¤³¤“³¤³¤‡¤“¤veP? hÿ1\h7róCJOJQJ^JaJ)jhÿ1\h7róCJOJQJU^JaJ hÿ1\hsy¹CJOJQJ^JaJ h`:ó5CJOJQJ\^JaJhq #@ˆúÿOJQJ^J h—`hq #@ˆúÿOJQJ^JaJh—`hq #@ˆúÿOJQJ^Jh—`hq #OJQJhq #hq #@ˆúÿOJQJ^Jhq #hq #OJQJ^J!jhq #hq #OJQJU^J'j†hq #hq #OJQJU^Jüý"“ŠŠ $Ifgdq #lkdú$$If–sÖ” Ö¦ÿ˜+€ò+Ö0ÿÿÿÿÿÿöò+ööÖÿÖÿÖÿÖÿ4Ö saögÖ9lÆ¦pÖ ÿÿ"#9D{nX ÆàÀ!$5$7$8$9DH$Ifgdq # Æ$Ifgdq #„kd$$If–sÖ” Ö0¦ÿÍ˜+€'€ËÖ0ÿÿÿÿÿÿöò+ööÖÿÿÖÿÿÖÿÿÖÿÿ4Ö saögÖ9lÆ¦pÖÿÿÿÿDEOWXxkZQ $Ifgdq # Æ„=$If^„=gdq # Æ$Ifgdq #‡kdX $$If–s4Ö” Ö0¦ÿÍ˜+€'`ËÖ0ÿÿÿÿÿÿöò+ööÖÿÿÖÿÿÖÿÿÖÿÿ4Ö saöf4gÖ9lÆ¦pÖÿÿÿÿXYlƒe\F ÆàÀ!$5$7$8$9DH$Ifgdq # $Ifgdq #škd$$If–s4Ö” ÖF¦ÿBÍ˜+€œ€‹ ËÖ0ÿÿÿÿÿÿöò+ööÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö saöf4pÖÿÿÿÿÿÿƒ„Ž–—~uuu $Ifgdq #€kdò$$If–s4Ö” Ö0¦ÿÍ˜+€'`ËÖ0ÿÿÿÿÿÿöò+ööÖÿÿÖÿÿÖÿÿÖÿÿ4Ö saöpÖÿÿÿÿ—˜™šfL<% Ævƒ„v„Šý$If^„v`„Šýgdÿ1\$„1&`#$/„´Ifgdÿ1\ ÆìÍ„„òþdÿ1$^„`„òþgdBa˜kd«$$If–s4Ö” ÖF¦ÿBÍ˜+€œ€‹ ËÖ0ÿÿÿÿÿÿöò+ööÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö saöpÖÿÿÿÿÿÿ©ª«¬Ë‘Ÿ ¡¢´»ÂóçÒÁ³¥ÁgYK=/hÿ1\hsy¹5OJQJ^Jhÿ1\hmM|5OJQJ^Jhÿ1\hmM|>*OJQJ^Jhÿ1\hsy¹>*OJQJ^J/jôhÿ1\hsy¹CJOJQJU^JaJ hÿ1\hsy¹CJOJQJ^JaJ)jhÿ1\hsy¹CJOJQJU^JaJhÿ1\h7ró5OJQJ^Jhÿ1\h7ró>*OJQJ^J hÿ1\h7róCJOJQJ^JaJ)jhÿ1\h7róCJOJQJU^JaJ/j|hÿ1\h7róCJOJQJU^JaJóôTUÅË u Ñ x!ó!…"#ïïï×××××Ã¶Ãžžž &F „h$„1&`#$/„´If`„hgdÿ1\ „v$If^„vgdÿ1\„v$„1&`#$/„´If^„vgdÿ1\„Â„>þ$„1&`#$/„´If^„Â`„>þgdÿ1\$„1&`#$/„´Ifgdÿ1\óôSTUZ[ijkš¶ÃÅÊËÐÑßàáó * íàÓÂ± ÓŒ Ó~p~±_Ó ÓK Ó~± Ó'jähÿ1\hsy¹OJQJU^J hÿ1\hsy¹CJ OJQJ^JaJ hÿ1\hH{5OJQJ^Jhÿ1\hsy¹5OJQJ^J'jlhÿ1\hsy¹OJQJU^J!jhÿ1\hsy¹OJQJU^J hÿ1\hsy¹CJOJQJ^JaJ hÿ1\h¿m-CJOJQJ^JaJhÿ1\hsy¹OJQJ^Jhÿ1\h7róOJQJ^J#hÿ1\h7ró5CJOJQJ^JaJ* + , > E H t u v „ … † ¤ Ð Ñ Ò à á â ! !!F!L!³!Ã!ëÚÍÀÍ²Í¡”€¡”r”ÚÍ^ÚÍÀÍ²P²Bhÿ1\h=.5OJQJ^Jhÿ1\hþl$5OJQJ^J'jLhÿ1\hsy¹OJQJU^Jhÿ1\h£z”5OJQJ^J'jÔhÿ1\h£z”OJQJU^Jhÿ1\h£z”OJQJ^J!jhÿ1\h£z”OJQJU^Jhÿ1\hsy¹5OJQJ^Jhÿ1\h@WOJQJ^Jhÿ1\hsy¹OJQJ^J!jhÿ1\hsy¹OJQJU^J'j\hÿ1\hsy¹OJQJU^JÃ!Ä!Æ!Ç!Õ!Ö!×!Ø!Ù!Ú!Û!à!á!â!ð!ñ!ò!" "<"="@"A"O"P"Q"S"U"Y"["\"j"ñãÐãºÐã¬ãžãñÐãˆÐã{ãmãÐãWÐãñãñÐã*j´hÿ1\hsy¹5OJQJU^Jhÿ1\hba5OJQJ^Jhÿ1\hsy¹OJQJ^J*j<hÿ1\hsy¹5OJQJU^Jhÿ1\h¢3M5OJQJ^Jhÿ1\hŸ;ï5OJQJ^J*jÄhÿ1\hsy¹5OJQJU^J$jhÿ1\hsy¹5OJQJU^Jhÿ1\hsy¹5OJQJ^Jhÿ1\h …5OJQJ^Jj"k"l"s"t"‚"ƒ"„"…"Å"Í"Ù"Ú"è"é"ê"ó"ô"õ"#ê×É¶É ¶’„w„d„Nd„@d„hÿ1\h …5OJQJ^J*jhÿ1\hF£5OJQJU^J$jhÿ1\hF£5OJQJU^Jhÿ1\hF£OJQJ^Jhÿ1\hF£5OJQJ^Jhÿ1\hsy¹5OJQJ^J*j¤hÿ1\hba5OJQJU^J$jhÿ1\hba5OJQJU^Jhÿ1\hba5OJQJ^J$jhÿ1\hsy¹5OJQJU^J*j,hÿ1\hsy¹5OJQJU^J#####h#i#j#k#l#z#{#|#}#—#™#Ä#ê×É·£‚wf‚Rf‚D‚6hÿ1\hsy¹5OJQJ^Jhÿ1\hsy¹>*OJQJ^J'jÀhÿ1\hsy¹OJQJU^J!jhÿ1\hsy¹OJQJU^Jhÿ1\hsy¹CJaJhÿ1\hsy¹OJQJ^J&hÿ1\hsy¹56CJOJQJ^JaJ&hÿ1\hba56CJOJQJ^JaJ#hÿ1\hF£5CJOJQJ^JaJhÿ1\hF£5OJQJ^J$jhÿ1\hF£5OJQJU^J*j”hÿ1\hF£5OJQJU^J#i#j#k#Ä#Å#$áYIIII$„1&`#$/„´Ifgdÿ1\‡kd$$If–lÖ”3Ö”ÿ˜+, Ö tà 6`”1”´Ö ÿæææÖ0ÿÿÿÿÿÿö,6öÖÿÖÿÖÿÖÿ”´4Ö4Ö l`Ö ÿæææaöpÖ ÿæææytÿ1\ Ævƒ„v„>þ$„1&`#$/„´If^„v`„>þgdÿ1\Ä#Å#É#Ê#Ø#Ù#Ú#û#$$$S&~''€'„'…'“'”'•'Ù'ù'ú'(((ïáÎá¸Î«áá«‰wáÎáaÎ«ááPá hÿ1\hsy¹CJOJQJ^JaJ*j°hÿ1\hsy¹5OJQJU^J#hÿ1\hsy¹5CJ OJQJ^JaJ hãhsy¹hÿ1\hmM|OJQJ^Jhÿ1\hH{5OJQJ^Jhÿ1\hsy¹OJQJ^J*j8hÿ1\hsy¹5OJQJU^J$jhÿ1\hsy¹5OJQJU^Jhÿ1\hsy¹5OJQJ^J hÿ1\hsy¹CJ OJQJ^JaJ $'€'(((ë×¿¿7‡kd($$If–lÖ”Á Ö”ÿ˜+, Ö tà 6`”1”´Ö ÿæææÖ0ÿÿÿÿÿÿö,6öÖÿÖÿÖÿÖÿ”´4Ö4Ö l`Ö ÿæææaöpÖ ÿæææytÿ1\„Ð„0ý$„1&`#$/„´If^„Ð`„0ýgdÿ1\„Ð$„1&`#$/„´If^„Ðgdÿ1\!„h$„1&`#$/„´If^„hgdÿ1\((,(×)Ø);*¡* +Œ+³+ß+íÛÖÑÑÌÇ¾^1 ÆA´h€€ € € €€€€€„ªÿ„hdÜ]„ªÿ^„hgdÉk8- ÆA´h€€ € € €€€€€„ªÿdÜ]„ªÿgdÉk8 ÆŒ gdÉk8gddY—gdX4RgdDT®gdoQ® ÆìÍdÿ1$gd±ù ÆìÍdÿ1$gdÓ“ (((*(+(,(Å(Ç())))(),)-).)<)ƒ)‹)íØÆ´£“†|k^T^F^<^2^h±ùOJQJ^JhDT®OJQJ^JhvuÃhÉk8>*OJQJ^JhÉk8OJQJ^JhvuÃhÉk8OJQJ^J hf5CJOJQJ\^JaJhoQ®OJQJ^Jhqm5OJQJ\^JhoQ®h4x5OJQJ\^J hznà5CJOJQJ\^JaJ#hËzp5>*CJOJQJ\^JaJ#hú2t5>*CJOJQJ\^JaJ)hO`÷hO`÷5>*CJOJQJ\^JaJ#h|sŒ5>*CJOJQJ\^JaJ‹)–))¤)©)ª)«)µ)½)Ó)Õ)Ö)×)Ø)Ù)ç)è)é)ñ)ü)**óæóÙóÏÅ»Ï±§“‰xkWxkJk=h†¦hmM|OJQJ^Jh†¦hà ÉOJQJ^J'jÜh†¦hŸkÛOJQJU^Jh†¦hŸkÛOJQJ^J!jh†¦hŸkÛOJQJU^JhŸkÛOJQJ^J&hfhoQ®5CJOJQJ\^JaJhoQ®OJQJ^JhmM|OJQJ^JhP²OJQJ^Jh6OJQJ^JhÉk8OJQJ^JhËzp5OJQJ\^JhŸkÛ5OJQJ\^Jh65OJQJ\^J*&*)*6*7*8*:*;*<*J*K*L*_*h*q*€*‘*ž*Ÿ*¡*¢*°*óæÛÐÅ¸®|rrg_gNAh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^JhX4ROJQJh†¦hX4ROJQJhX4ROJQJ^J'jRh†¦hX4ROJQJU^Jh†¦hX4ROJQJ^J!jh†¦hX4ROJQJU^JhÉk8OJQJ^Jh†¦h¼{´OJQJ^Jh†¦hÈ?kOJQJh†¦h6U¿OJQJh†¦hdY—OJQJh†¦hdY—OJQJ^Jh†¦hÈ?kOJQJ^J°*±*²*¿*É*Ñ*Ò*ï*ü*ý*+ +++++$+0+…+‹+Œ+Ž+++ëÚÌ¾Ì°Ì¢”‰|Úo[ÚÌ¾ÌMÌoÚoh†¦h§$—OJQJ\^J'j>h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^Jh†¦hdY—OJQJ^Jh†¦hdY—OJQJh†¦h6U¿OJQJ\^Jh†¦hÈ?kOJQJ\^Jh†¦hi3ŸOJQJ\^Jh†¦hý½OJQJ\^Jh†¦hÉk8OJQJ\^J!jh†¦hÉk8OJQJU^J'jÈh†¦hÉk8OJQJU^J+ž+Ÿ+ +³+Þ+ß+à+î+ï+ð+ú+ ,;,<,J,K,L,n,†,,—,,½,¾,¿,à,ëÚÍ¿Í¿ÚÍ«ÚÍ¿Íšyšl_lUHh†¦hyÓOJQJ^Jh†¦OJQJ^Jh†¦h@WOJQJ^Jh†¦hSa\OJQJ^J'j¤h†¦hqmOJQJU^Jh†¦hqmOJQJ^J!jh†¦hqmOJQJU^J'j,h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ\^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^J'j´h†¦hÉk8OJQJU^Jß+,;,¾,¿,-b-öÆ–hh61 ÆA´h€€ € € €€€€€„ªÿ„hdÜ]„ªÿ^„hgdyÓ- ÆA´€€ € € €€€€€„ªÿdÜ]„ªÿgdyÓ0 Æ>h€€ € € €€€€€„ªÿ„hdÜ]„ªÿ^„hgdqm0 Æ>h€€ € € €€€€€„ªÿ„hdÜ]„ªÿ^„hgdÉk8„h`„hgdÉk8à,-------_-b-c-q-r-s-t-u-.. .?.@.A.B.P.Q.R.S.T.§.öéØéÄØé·éØé£ØéØ™…ØxØéØédØéSIhÚc?OJQJ^J!jh—`hÚc?OJQJU^J'jËh†¦hyÓOJQJU^Jh†¦hyÓ0JCJaJ'jh†¦hª-”OJQJU^Jhª-”OJQJ^J'j’h†¦hyÓOJQJU^Jhª-”hyÓOJQJ^J'jh†¦hyÓOJQJU^J!jh†¦hyÓOJQJU^Jh†¦hyÓOJQJ^JhO1ÙOJQJ^Jb-A.Ç.9/:/m/ˆ0ÍÍÀ’d8, Æ>h€€ € € €€€€€„ªÿdÜ]„ªÿgd†¦- ÆA´h€€ € € €€€€€„ªÿdÜ]„ªÿgd†¦- ÆA´h€€ € € €€€€€„ªÿdœÿ]„ªÿgd†¦ ÆŒ „h^„hgd§$—1 ÆA´h€€ € € €€€€€„ªÿ„hdÜ]„ªÿ^„hgdyÓ§.¨.©.Å.Æ.Ç.È.Ö.×.Ø.ì.8/9/M/\/m/n/|/}/~//ëÚÑÚÄ³¦’³¦…wj\jKj7Kj'j°!hy'h†¦OJQJU^J!jhy'h†¦OJQJU^Jhy'h†¦5OJQJ^Jhy'h†¦OJQJ^Jhy'h§$—OJQJ\^Jhy'hÉk8OJQJ^J'j:!h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^Jh†¦hyÓOJQJ^Jh—`hÚc?0J!jh—`hÚc?OJQJU^J'j? h¼ELhÚc?OJQJU^J/—/˜/304050M0N0Y0`0a0d0ˆ0‰0—0˜0™0š0›0516171g1h1i1j1x1y1z1{1|1(2óâØÄâ·âªªªâª‰âªâØuâ·âªâªaâªâØ'jð%hy'h†¦OJQJU^J'jI$hy'hª-”OJQJU^J'jÑ#hy'h†¦OJQJU^Jhy'hO1ÙOJQJ^Jhy'h†¦OJQJ^Jhy'h†¦0JCJaJ'j("hy'hª-”OJQJU^Jhª-”OJQJ^J!jhy'h†¦OJQJU^Jhy'h(¯OJQJ^Jˆ0i1V2W2Å2¢3ë3,4€44‚5ƒ5<6=6œ6f7Z8Á8ÓÓÊÁ¸³®¸¸¥¥ÁÁÁ˜˜“gddY—„„òþ^„`„òþgdý½ ÆŒ gdfgdÉk8gd§$— ÆŒ gdÉk8 ÆŒ gd±ù ÆŒ gd†¦, Æ>h€€ € € €€€€€„ªÿdÜ]„ªÿgd†¦(2)2*2T2U2V2W2n2–22Å2Æ2Ô2Õ2Ö2×2†3ëÚÍÚÀœ‹z‹i\Hi5*hª-”OJQJ\^J$jh†¦hi3ŸOJQJU\^J'j3(h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^J!h\<Îh656>*OJQJ^J!h\<ÎhŸkÛ56>*OJQJ^J!h\<ÎhÉk856>*OJQJ^J$h\<Îh±ù56>*°¿´³²Ï´³°À^´³³ó†¦³ó†¦°¿´³²Ï´³°÷´³³ó²â'³ó†¦0´³°ä´³²¹´³!Âá³ó²â'³ó†¦°¿´³²Ï´³±«°÷´³'Âá³ó&³ó²â'³óª-”°¿´³²Ï´³±«°÷´³†3‡3ˆ3Ÿ3 3¢3£3±3²3³3é3ê3ë3ì3ú3ê×É×»¨™ƒ¨t±ð°Â¹ó9³ó†¦³óÉk8°ä´³°¿´³²Ï´³!Âá³ó†¦³óÉk8°ä´³°¿´³²Ï´³±«³ó†¦³ó§$—5C´³°¿´³²Ï´³³ó†¦³ó°ù¹ó°ä´³°¿´³²Ï´³°÷´³³ó†¦³ó§$—°ä´³°¿´³²Ï´³°÷´³+Âá³ú*³ó†¦³ó†¦°ä´³°¿´³²Ï´³±«°÷´³³ó†¦³ó†¦°ä´³°¿´³²Ï´³°÷´³%Âá³ó†¦³ó†¦°ä´³°¿´³²Ï´³±«°÷´³³ó†¦³óÉk8°¿´³²Ï´³°À^´³³ó†¦³óÉk80´³°ä´³°Àa´³$Âá³ó†¦³ó¾±3Ÿ°¿´³²Ï´³±«°À^´³*Âá©(³ó†¦³óª-”°¿´³²Ï´³±«°À^´³ú3û3ü3)4+4,4-4;4<4=4>4g4o4€444»4ëÚË¼®|n`nQ?+&hÆ6—hf>*CJOJQJ\^JaJ#h±ùhfCJOJQJ\^JaJh¼{´CJOJQJ\^JaJh†¦hŸkÛOJQJ\^Jh†¦hÉk8OJQJ\^J'jf+h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^Jh†¦hÉk85CJOJQJh†¦hrFCJOJQJ^Jh†¦hÉk8CJOJQJ^J!jh†¦hÉk8CJOJQJU'jð*h†¦hÉk8CJOJQJU»415[5l5q5€55‚5ƒ5¡5¨5°5¸5Ï5ß5ä5;6<6=6R6Y6íÛíÛíÛíÉ¸§¸•¸‡¸§vhWF!h\<Îh~aJ56>*OJQJ^J!h\<ÎhÉk856>*OJQJ^Jh†¦56>*OJQJ^J h\<Îh±ùCJOJQJ^JaJhÆ6—CJOJQJ^JaJ#hÆ6—h¼{´>*CJOJQJ^JaJ h\<ÎhrFCJOJQJ^JaJ h\<Îh¼{´CJOJQJ^JaJ#h±ùh¨TwCJOJQJ\^JaJ#h±ùhÓ“CJOJQJ\^JaJ#h±ùhfCJOJQJ\^JaJY6›6œ66«6¬66®6¯6¶6·6¾6¿6Ã6Ä6Ê6Ù6Y7d7e7f7g7u7v7w7x7y7}7~7„7…777”7•7œ7Ÿ7îàÏÂ®ÏÂ ’ ’ ’ ’ „v„ ÏÂbÏÂ ’ ’ ’ ’ ’ 'jR,h†¦hÉk8OJQJU^Jh†¦hôl‚OJQJ\^Jh†¦hý½OJQJ\^Jh†¦hê5ÕOJQJ\^Jh†¦hÉk8OJQJ\^J'jÜ+h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^Jh\<ÎhÉk8OJQJ\^J!h\<Îh‘~Ä56>*OJQJ^J$Ÿ7§7µ7Y8Z8[8i8j8k8t8ƒ8’8Á8Â8Ð8Ñ8Ò8ø8ú8ñãÕÅ´§“´ã…xkZM9ZM/hÕS‰OJQJ^J'j>-hy'h…ÿOJQJU^Jhy'hÉßOJQJ^J!jhy'hÉßOJQJU^Jhy'hÉk8OJQJ^Jhy'hdY—OJQJ^Jhy'hÉk8OJQJ\^J'jÈ,h†¦hÉk8OJQJU^Jh†¦hÉk8OJQJ^J!jh†¦hÉk8OJQJU^J*h†¦hÉk8OJQJ\^Jh†¦hý½OJQJ\^Jh†¦hÉk8OJQJ\^Jh†¦h‘~ÄOJQJ\^Jú8ÿ89,9.9H9N9 9¡9¢9±9¸9È9É9Ë9Ì9Ú9Û9Ü9îàîÌîàî¿²¡¡€p_R>³å'Âá¶-³ó³Ý4¸é³óÉk8°¿´³²Ï´³±«°÷´³³ó³Ý4¸é³óÉk8°¿´³²Ï´³°÷´³!Âá³ó³Ý4¸é³óÉk8°¿´³²Ï´³±«°÷´³³ó³Ý4¸é³ó“wŸ5>*°¿´³²Ï´³°÷´³³ó³Ý4¸é³óÉk85>*°¿´³²Ï´³°÷´³!³ó³Ý4¸é³óú2³Ù56>*°¿´³²Ï´³°÷´³!³ó³Ý4¸é³óÉk856>*°¿´³²Ï´³°÷´³³ó°À<ÎhÉk8OJQJ^Jhy'hÕS‰OJQJ^J'hy'hÕS‰6>*µþ*°¿´³²Ï´³°÷´³±è³ó³óÕS‰µþ*°¿´³²Ï´³°÷´³±è³ó!³ó²â'³óÕS‰µþ*°¿´³²Ï´³°÷´³±è³óÁ8±õ9¡9¢9Ë9;Ë;¯<Ý<Þ<úúíäÓÓÆÁ¸ $Ifgd`:ógdÉk8„h„˜þ^„h`„˜þgd$u Æ‘„h„˜þ^„h`„˜þgd†¦ Æ‘gdÉk8„„òþ^„`„òþgdÕS‰gdÕS‰ Ü9ß9b:m:z:;; ;;;;;;;_;Ê;Ë;Ì;Ú;Û;Ü;Þ;ß;æ;ì;ú;<<3<óæóæÙæÈæ´È¦æóæ™Œ{Œg{ŒóŒ]ŒPŒPhX4Rh‘~ÄOJQJ^JhX4ROJQJ^J'j¢.hX4RhaOJQJU^J!jhX4RhaOJQJU^JhX4RhaOJQJ^JhX4Rh~aJOJQJ^JhX4RhÉk8OJQJ\^J'j,.hX4RhÉk8OJQJU^J!jhX4RhÉk8OJQJU^JhX4RhF’OJQJ^JhX4RhÉk8OJQJ^JhX4Rh$uOJQJ^J3<4<†<‡<ˆ<¦<§<<®<¯<°<¾<¿<À<Á<Ã<Ý<Þ<ß<à<ð<îáÍî¼«¼îžžyžlžhd]L hO`÷h`:óCJOJQJ^JaJhnrhznàhdY—h±ùhX4Rh3ROJQJ^J'j0hX4RhÉk8OJQJU^J!jhX4RhÉk8OJQJU^JhX4RhÉk8OJQJ^J!hX4Rh$u0JB*CJaJphÿ!hX4Rha0JB*CJaJphÿ'j/hX4RhàOJQJU^JhX4Rh!îOJQJ^J!jhX4Rh6OJQJU^JÞ<ß<ð<[=]=Ç=È=?>f>g>˜˜“˜˜‰‰z Æ$1$Ifgdÿ1\ Æ1$gd`:ógdu8*gd`:óbkd0$$If–lÖ”XÖÕ*¸)Ö0ÿÿÿÿÿÿö6ööÖÿÖÿÖÿÖÿ4Ö laö‰ ð<ñ<ò<ô<%=Y=Z=[=\=]=_=`=–=º=Æ=Ç=È=Í=;>e>f>h>i>j>k>>Ž>éÜÎÜÎÀÎéÎÜÎÜÎµ§™§ŽµƒucŽVƒIhí)Úh`:óOJQJ^JhL5¢h`:óOJQJ^J#h@_6h@_65CJOJQJ^JaJhÿ1\h@_65OJQJ^Jh`:ó5OJQJ^Jh@_65OJQJ^Jhu8*h¦_(5OJQJ^Jhu8*h@_65OJQJ^JhÙ`t5OJQJ^Jhu8*h9y5OJQJ^Jhu8*h`:ó5OJQJ^Jhu8*h`:óOJQJ^J,jhu8*h¦_(OJQJU^JmHnHug>h>i>º>6?˜?™?—ƒƒt Æ´$1$Ifgdÿ1\ Æf1$gd£z” Æ1$gd`:óhkd 1$$If–lÖÖ´¼++ tàÖ0ÿÿÿÿÿÿö6öÖÿÖÿÖÿÖÿ4Ö4Ö laö ytÿ1\Ž>>>ž>Ÿ>¤>¥>³>´>µ>¶>¹>º>¾>ä>å>:?ƒ?Š?‹?–?˜?š?›?Ÿ? ?îáÍîáîá¹î¯á¤¯šš€vi€š\¯áJ#h6U¿h`:ó5CJ OJQJ^JaJ hÿ1\hI0jOJQJ^Jh£z”h@WOJQJ^Jh@WOJQJ^Jh£z”h£z”OJQJ^Jh’K¨h£z”OJQJ^Jh£z”OJQJ^Jh`:ó5OJQJ^Jh`:óOJQJ^J'jï1h’K¨h`:óOJQJU^J'j‡1h’K¨h`:óOJQJU^Jh’K¨h`:óOJQJ^J!jh’K¨h`:óOJQJU^J™?š? ?}@ÛAÜA—‰{dN ÆìÍdÿ$1$Ifgdÿ1\ Æ´T„´„Lÿdÿ1$^„´`„Lÿgd@_6 Æ„´1$^„´gdYRÿ Æ´„´1$^„´gd`:óhkdW2$$If–lÖÖ´¼++ tàÖ0ÿÿÿÿÿÿö6öÖÿÖÿÖÿÖÿ4Ö4Ö laö ytÿ1\ ?@"@#@a@b@c@z@{@|@}@€@”@ @È@é@ý@ÿ@A{AíÛÄÛªÄ–ÄÛ„yk`kR`G<`h~aJ5OJQJ^Jh¥\¬5OJQJ^JhºuÊh`:ó5OJQJ^Jh`:ó5OJQJ^JhA h`:ó5OJQJ^Jh@_65OJQJ^J#h"êhý½5CJOJQJ^JaJ'h"êh`:ó0J5>*B*CJaJphÿ2jÑ2h"êh`:ó5CJOJQJU^JaJ,jh"êh`:ó5CJOJQJU^JaJ#h"êh`:ó5CJOJQJ^JaJ#hj8h`:ó5CJOJQJ^JaJ{A|AŠA‹AŒAA‘AŸA A¡A¥A¦AµA½AÚAÛAÜAÝAÞAßAîáÍî¾îáªî¾žá”á†xdPBh—GÌCJOJQJ^JaJ&hÓ“h`:ó5CJOJQJ\^JaJ&hÿ1\hI0j5CJOJQJ\^JaJhÿ1\hI0jOJQJ\^Jh~aJh`:ó5OJQJ^Jh;}OJQJ^Jh`:óOJQJ^JaJ'j4hºuÊh`:óOJQJU^JhºuÊh`:óOJQJ^JaJ'j¤3hºuÊh`:óOJQJU^JhºuÊh`:óOJQJ^J!jhºuÊh`:óOJQJU^JÜAÝAÞAðA”BÃBCC—}xgVAA ÆÍ„v„òþdÿ1$^„v`„òþgd¡,o ÆÍ„hdÿ1$^„hgd÷nF &F ÆÍdÿ1$gdŸkÛgd`:ó ÆìÍ„„òþdÿ1$^„`„òþgd`:óhkd4$$If–lÖÖ´¼++ tàÖ0ÿÿÿÿÿÿö6öÖÿÖÿÖÿÖÿ4Ö4Ö laö ytÿ1\ßAáAðAúAB B7BUB’B“B”B•B£B¤B¥B§B¬B·BÂBÃBÄBïÞÌ½Ì®Ÿ½ŸÌ‘‡v‘fYLYf;!jhºuÊh÷nFOJQJU^JhjL“OJQJ\^JaJh?1¾OJQJ\^JaJhµrYh÷nFOJQJ\^JaJ!j 5h÷nFOJQJU^Jh÷nFOJQJ^Jjh÷nFOJQJU^JhŸR×5OJQJ\^JaJhKA5OJQJ\^JaJhjL“5OJQJ\^JaJ"hA h÷nF5OJQJ\^JaJ h§$—h÷nFCJOJQJ^JaJ h§$—h§$—CJOJQJ^JaJÄBÒBÓBÔB×BëBCCCC=CÎCÐCIDKDóßÎ¾±¤±—ˆvcS@0hÿ1\hÛcOJQJ\^JaJ%hÿ1\hÛc56OJQJ\^JaJhÿ1\hÌLQOJQJ\^JaJ%hÿ1\hÌLQ56OJQJ\^JaJ"hÌLQhÌLQ5OJQJ\^JaJh eì5OJQJ\^JaJhÌLQOJQJ\^JaJhu8*OJQJ\^JaJhjL“OJQJ\^JaJhºuÊh÷nFOJQJ\^JaJ!jhºuÊh÷nFOJQJU^J'j~5hºuÊh÷nFOJQJU^JhºuÊh÷nFOJQJ^JC=CÎCÏCÐCIDJDêÕÃHÕÃ{kdò5$$If–lÖÖ0´R&0*ž%Þ tàÖ0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö ytÿ1\ ÆÍdÿ$1$Ifgdÿ1\ &F ÆÍdÿ$1$Ifgdÿ1\ ÆÍ„v„òþdÿ1$^„v`„òþgd¡,oJDKDLDNEOEfE„weR? ÆhÍ„Âdÿ1$^„Âgd¦,Á ÆhÍ„Zdÿ1$^„Zgdu8* &F ÆhÍdÿ1$gdŸkÛ ÆÍdÿ1$gd6U¿{kdz6$$If–lÖÖ0´R&0*ž%Þ tàÖ0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö ytÿ1\KDLDYD[DgDhDiDEEE EEEEEE!E"E#EMENEòâÒÅÒ°£‹°}o}aSaS°Câ6h÷nF5OJQJ^JaJh$Z1hÙ`t5OJQJ^JaJh$Z1hÝ:i0J5CJaJh$Z1h 6Ñ0J5CJaJh$Z1h÷nF0J5CJaJh$Z1h$Z10J5CJaJ.j7h$Z1hª-”5OJQJU^JaJhª-”5OJQJ^JaJ(jh$Z1hO`÷5OJQJU^JaJh$Z15OJQJ^JaJh$Z1h÷nF5OJQJ^JaJhA h÷nF5OJQJ^JaJh6U¿5OJQJ^JaJNEOEXEeEfEÛEòEöEFFF3FBFKFUFVF^F_FfFiFoFòåÓåÁ¯ Á ‘ ‚sdU‚ ‘ Ehÿ1\hÙ`t5OJQJ^JaJhÿ1\hcILOJQJ^JaJhÿ1\h·@”OJQJ^JaJhÿ1\h6iOJQJ^JaJhÿ1\h$Z1OJQJ^JaJhÿ1\h«y¯OJQJ^JaJhÿ1\h &OJQJ^JaJ"hÿ1\h³–56OJQJ^JaJ"hÿ1\h &56OJQJ^JaJ"hÌLQh¦,Á5OJQJ\^JaJh¦,Á5OJQJ^JaJhu8*5OJQJ^JaJfEôEõEöEFFàÍR1Í &F Æ ÐVìÍ„0ýdÿ$1$5$9DIf`„0ýgdÿ1\{kd¯8$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö ytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\ &F Æ ÐVÍ„Vdÿ$1$5$9DIf^„Vgdÿ1\FFgFhFiVV ÆìÍdÿ$1$Ifgdÿ1\•kdE9$$If–lÖÖ0´R&0*ž%Þ Ö t¿Öÿÿÿ³³³Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿ³³³ytÿ1\hFiFÃFÄF„mZ ÆìÍdÿ$1$Ifgdÿ1\ ÆìÍdÿ$1$5$9DIfgdÿ1\{kd:$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö ytÿ1\oFpFqFÅFÈFÉFËFÌFÍFèFïFñFüFGGGG0GG€G‚GñâñÐ¾Ð¯â¯ñ ¯Ž|j|XF|7hÿ1\h &OJQJ^JaJ"hÿ1\h#œ56OJQJ^JaJ"hÿ1\h›‚56OJQJ^JaJ"hÿ1\hâR€56OJQJ^JaJ"hÿ1\h &56OJQJ^JaJ"hÿ1\hŸkÛ56OJQJ^JaJhÿ1\häPÐOJQJ^JaJhÿ1\h«y¯OJQJ^JaJ"hÿ1\hÊ´56OJQJ^JaJ"hÿ1\h«y¯56OJQJ^JaJhÿ1\hÛcOJQJ^JaJhÿ1\hÙ`tOJQJ^JaJÄFÅFúFûFxaN ÆìÍdÿ$1$Ifgdÿ1\ ÆìÍdÿ$1$5$9DIfgdÿ1\†kdŠ:$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿÿytÿ1\ûFüF1G€GGxW@- ÆìÍdÿ$1$Ifgdÿ1\ ÆìÍdÿ$1$5$9DIfgdÿ1\ &F Æ ÐVìÍ„0ýdÿ$1$5$9DIf`„0ýgdÿ1\†kd);$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿÿytÿ1\G‚GHéHêH,IxeeRR ÆhÍ„Âdÿ1$^„ÂgdÕS‰ ÆìÍ„´dÿ1$^„´gdÓ“†kdÈ;$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿÿytÿ1\‚GHH#H:H?HDHQHzH}HŒHHšHHèHéH,IŒIŽIIIÈIÊIÌIÍIïÞÍÞÍ¿ÞÍÞÍ®Í®Í “rcrQrChÓ“CJOJQJ^JaJ"hÿ1\hˆ#956OJQJ^JaJhÿ1\hˆ#9OJQJ^JaJhÿ1\hÕS‰OJQJ^JaJ"hÿ1\hÕS‰56OJQJ^JaJhÕS‰5OJQJ^JaJh~aJCJOJQJ^JaJ hÛch.!ÎCJOJQJ^JaJh$Z1CJOJQJ^JaJ hÛchÙ`tCJOJQJ^JaJ hÛch6iCJOJQJ^JaJ hÛchfjCJOJQJ^JaJ,IIŽIIIàÍÍF†kdu<$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿÿytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\ &F Æ ÐVÍ„Vdÿ$1$5$9DIf^„Vgdÿ1\IÉIÊIËIÌIÞÇ´-†kd=$$If–lÖÖ0´R&0*ž%Þ t¿Ö0ÿÿÿÿÿÿö6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laö pÖÿÿÿÿÿÿÿÿÿÿÿÿytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\ ÆìÍdÿ$1$5$9DIfgdÿ1\ &F Æ ÐVìÍ„0ýdÿ$1$5$9DIf`„0ýgdÿ1\ÌIÍIÎIšJ›JœJJžJììÒ¿¿U? ÆìÍ„Ðdÿ1$5$9D^„Ðgd pjkd³=$$If–lÖ”^ÖŠ*|) tàÖ0ÿÿÿÿÿÿö6öÖÿÖÿÖÿÖÿ4Ö4Ö laözytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\ &F ÆÍ„„òþdÿ1$^„`„òþgdŸkÛ ÆìÍ„´dÿ1$^„´gdÓ“ÍIÎIéIêI™JšJJžJêJëJðJñJÿJKKKKKKKK K!KïâÕâÈ¹¨˜‹sbsVsEsV9h$rOJQJ^JaJ!j§>h pOJQJU^Jh pOJQJ^JaJ!j1>h pOJQJU^Jjh pOJQJU^Jh pOJQJ^Jh p5OJQJ^JaJhA h p5OJQJ^JaJ hI0jhu8*CJOJQJ^JaJhÿ1\h3ROJQJ^JaJh§$—5OJQJ^JaJh^k5OJQJ^JaJh#œ5OJQJ^JaJ hÓ“hˆ#9CJOJQJ^JaJžJëJKAKBKCKDKEKéÚÚÇÇ_G ÆhÍ„Â„>þdÿ1$^„Â`„>þgdrK¦hkd?$$If–lÖÖŠ*|) tàÖ0ÿÿÿÿÿÿö6öÖÿÖÿÖÿÖÿ4Ö4Ö laözytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\ ÆìÍdÿ1$gd p &F ÆÍdÿ1$5$9DgdŸkÛ!K9K?K@KAKBKCKDKEKoKvKŸKûKüKýKþKÿKLLLôèôÜÍ¾Í “ †y† lbQDh’K¨hngáOJQJ^J!jh’K¨hngáOJQJU^JhngáOJQJ^JhngáhngáOJQJ^Jh 75OJQJ^JaJheU˜5OJQJ^JaJh@W5OJQJ^JaJhngá5OJQJ^JaJ hÛÆ5CJOJQJ\^JaJhÿ1\hJH®OJQJ^JaJhÿ1\hú2tOJQJ^JaJhú2tOJQJ^JaJh3ROJQJ^JaJh pOJQJ^JaJEK¹KLL„LÉLÊLîLËMÌMÍMïï××××¿¡…… ÆìÍdÿ$„Š„& #$/„´1$Ifgd?1¾ &F ÆÍ„„îþdÿ1$5$9D^„`„îþgdþDœ ÆhÍ„Â„>þdÿ1$^„Â`„>þgdÛÆ ÆhÍ„Â„>þdÿ1$^„Â`„>þgdrK¦ ÆhÍdÿ1$gdeU˜ LLLLL L.L/L0L1L4LxL|L„LˆL‰L—L˜L™LœLÀLÇLÈLÉLÊLëÚÍÃÚÍ¯Ú¥Í¥›¥ÃŠ}iŠ}Ã_ÃRA hngá5CJOJQJ\^JaJhfj5OJQJ^JaJh@WOJQJ^J'jg@h’K¨hfjOJQJU^Jh’K¨hfjOJQJ^J!jh’K¨hfjOJQJU^JheU˜OJQJ^JhngáOJQJ^J'jÿ?h’K¨hngáOJQJU^JhfjOJQJ^Jh’K¨hngáOJQJ^J!jh’K¨hngáOJQJU^J'j—?h’K¨hngáOJQJU^JÊLËLÍLÕLìLíLîLM7M?MLMZM[MdMgMoMÊMËMÌMÍMÎMïÛÇ¶Ç¢’…x…k…’k’k\PD8h?1¾OJQJ^JaJhõ žOJQJ^JaJhÉßOJQJ^JaJhvEVhoQ®OJQJ^JaJhþDœ5OJQJ^JaJhë H5OJQJ^JaJhâR€5OJQJ^JaJh–H|hrK¦5OJQJ^JaJ&hO`÷hÛÆ5CJOJQJ\^JaJ hë H5CJOJQJ\^JaJ&hO`÷hrK¦5CJOJQJ\^JaJ&hO`÷hO`÷5CJOJQJ\^JaJ h—GÌ5CJOJQJ\^JaJÍMÎMÏMNÇNÞNJOKO“ŠŠxiRR ÆìÍ„8„Èûdÿ1$^„8`„ÈûgdP @ ÆìÍdÿ1$gd . &F ÆìÍdÿ1$gd .„^„gdO`÷kkdÏ@$$If–lÖ”^Ö”ÿÔ(@) 6 ”Š””´Ö0ÿÿÿÿÿÿö6ööÖÿÖÿÖÿÖÿ”´4Ö laöÎMÏMNN4NjNoNwN~NN€NÆNÈNÉN×NØNÙNÞNßNàNîNïNðNñNôæØÊØ¼Ø¼¯¢•‹}‹l}`\T\ITC h .aJjÓAh .Ujh .Uh .h .OJQJ^JaJ!j]Ah .OJQJU^Jjh .OJQJU^Jh .OJQJ^JhÉßhÓ“OJQJ^Jh .h .OJQJ^Jh–H|hO`÷OJQJ^Jhãh²;5OJQJ^Jhãh~aJ5OJQJ^JhãhO`÷5OJQJ^Jh–H|hO`÷5OJQJ^Jh\<Î5OJQJ^JñNôNöNOO O#O&O'OIOJOKO”OPPPP!P"P#P(P)PñåØÎÁØ·Î£œŽ€ŽrdZId=9hQ $hQ $OJQJ^JaJ!jIBhQ $OJQJU^JhQ $OJQJ^JjhQ $OJQJU^Jhãh .5OJQJ^JhãhmM|5OJQJ^Jhãh–H|5OJQJ^Jh–H|h™hO`÷OJQJ^Jh~aJOJQJ^Jh™P,OJQJ^Jh–H|hi3ŸOJQJ^Jhi3ŸOJQJ^Jh–H|h .OJQJ^Jh6U¿OJQJ^JaJh .h .OJQJ^JaJKOP(P¿QÉQRR`R‡SˆS¨S0TíÚÆÆ¶©©ššk! &F ÆÐV„V„ªþdÿ$1$5$9DIf^„V`„ªþgdÿ1\ ÆÍdÿ1$gd–H| ÆhÍdÿ1$gdcIL ÆÐ„^„gdÙ-Ý$ ÆÍdÿ1$a$gd$r ÆÐ„ì„8„0ý^„8`„0ýgdôl‚ ÆìÍ„Ðdÿ1$^„ÐgdQ $ &F ÆìÍdÿ1$gdÙ-Ý)P*P8P9P:P;P?PAPšP¡PÈPÑPÒPQ‚QƒQ•Q–QœQ±Q»Q¼Q¾Q¿QÈQ÷óè÷âÓÇ»®¡®†re®¡X¡NDNhþDœOJQJ^Jh .OJQJ^JhºuÊh .OJQJ^JhºuÊh–H|0JCJaJ'j5ChºuÊhª-”OJQJU^Jhª-”OJQJ^J!jhºuÊhP @OJQJU^JhºuÊh÷OJQJ^JhºuÊh–H|OJQJ^Jh™P,OJQJ^JaJh$rOJQJ^JaJhºuÊhQ $OJQJ^JaJ hQ $aJj¿BhQ $UhQ $jhQ $UÈQÉQÐQÑQÒQÔQØQÚQÞQßQéQíQîQòQýQþQRRRRR$RöáÏá½«½áÏáÏá”áÏá‚saP>#hU„h$r5CJOJQJ^JaJ hU„hÙ-ÝCJOJQJ^JaJ#hU„hÙ-Ý5CJOJQJ^JaJh—GÌ5CJOJQJ^JaJ#h@_6h$r5CJOJQJ^JaJ,hþ{»h$r56>*CJOJQJ\^JaJ#hú2t5>*CJOJQJ\^JaJ#h™5>*CJOJQJ\^JaJ#h$r5>*CJOJQJ\^JaJ)hþ{»h$r5>*CJOJQJ\^JaJhÙ-ÝOJQJ^J$R1RVR_R`RmRoRtR|R}RSSSZS[S\SfS†S‡SˆSíÛíÊºª~q\~N~ªºAAhÿrø5OJQJ^JaJhQ hû~³0J5CJaJ(jEhª-”5OJQJU^JaJhª-”5OJQJ^JaJ"jhQ 5OJQJU^JaJhû~³5OJQJ^JaJhcIL5OJQJ^JaJh$Z1hcIL5OJQJ^JaJhA hcIL5OJQJ^JaJ hU„h–H|CJOJQJ^JaJ#hU„h$r5CJOJQJ^JaJ#hU„h–H|5CJOJQJ^JaJˆSŽSS¡S¦S§S¨SÎSÛS.T/T0T2TVT\TÜTÞTáTâTäTðãðÖðÈ¹ª¹›¹‰zkz¹YJ;h]\²6OJQJ\^JaJh$r6OJQJ\^JaJ"hÿ1\h–H|5OJQJ\^JaJhÿ1\hìo•OJQJ^JaJhÿ1\h–H|OJQJ^JaJ"hÿ1\h]\²5OJQJ\^JaJhÿ1\hcILOJQJ^JaJhÿ1\hë HOJQJ^JaJhÿ1\h]\²OJQJ^JaJh]\²h–H|5OJQJ^Jh]\²5OJQJ\^Jh$r5OJQJ\^Jh]\²h–H|5OJQJ\^J0T1T2TßTàTìoMì! &F ÆÐV„V„ªþdÿ$1$5$9DIf^„V`„ªþgdÿ1\}kd·F$$If–lÖ”ÓÖ0$+$x tàÖ0ÿÿÿÿÿÿö+6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laölytÿ1\ ÆìÍdÿ$1$Ifgdÿ1\àTáTâTVVV*VkV…VçVbW‚ssssniZZZ ÆìÍdÿ1$gdí²gd–H|gdçIš ÆìÍdÿ1$gd–H|}kdCG$$If–lÖ”ÓÖ0$+$x tàÖ0ÿÿÿÿÿÿö+6öÖÿÿÖÿÿÖÿÿÖÿÿ4Ö4Ö laölytÿ1\ äTèTëTU UDUEUHU’U•U¤U¬UÅUÊUÔUÛU VVVVVîÞÏ½Ï®Þ¡”„”„”„wj„]P@h]Rkh¿T6OJQJ^JaJhþDœ6OJQJ^JaJh–H|6OJQJ^JaJhYRÿ6OJQJ^JaJh|sŒ6OJQJ^JaJh]Rkh$r6OJQJ^JaJh$r6OJQJ^JaJhÆ6—6OJQJ^JaJh$r6OJQJ\^JaJ"h]Rkh–H|6OJQJ\^JaJhú2t6OJQJ\^JaJh]Rkh–H|6OJQJ^JaJ"h]Rkh–H|6OJQJ\^JaJVV)V*VVV[VjVkVpVqVV€VVŠV‹V™VšV›VŸV¡V¹VÙVïÛÊººž|f||P|D8h@_6OJQJ^JaJhO@LOJQJ^JaJ+jEHhQ $hí²OJQJU^JaJ+jÏGhQ $hí²OJQJU^JaJ%jhQ $hí²OJQJU^JaJhQ $hí²OJQJ^JaJhQ $hÈ?kOJQJ^JaJh!î5OJQJ^JaJhºuÊhí²5OJQJ^JaJ hºuÊhçIšCJOJQJ^JaJ&hºuÊhçIš5CJOJQJ\^JaJ h—GÌ5CJOJQJ\^JaJÙVÚVåVìVíVûVüVýVWWWW@WOWeWfWgWoWpWqW”W•WôäôÑÂ¬ÑÂô Âôäô•„p_KpAh–H|OJQJ^J&hmM|hH{5>*CJOJQJ^JaJ hH{5>*CJOJQJ^JaJ&hmM|h–H|5>*CJOJQJ^JaJ hÖ5>*CJOJQJ^JaJhO@LhO@LOJQJh¦,ÁOJQJ^JaJ+j»HhQ $hO@LOJQJU^JaJhQ $hO@LOJQJ^JaJ%jhQ $hO@LOJQJU^JaJhO@LhO@L>*OJQJ^JaJhO@LOJQJ^JaJbWcWdWeWgW”W•W°W^X_Xããwrjb]]T $Ifgds+Ogd–H|$a$gd–H|$a$gdí²gdþDœkkd1I$$If–lÖ”^Ö”ÿÔ(@) 6 ”Š””´Ö0ÿÿÿÿÿÿö6ööÖÿÖÿÖÿÖÿ”´4Ö laö ÆìÍdÿ$„Š„& #$/„´1$Ifgddñ •W–W£WW¯W°W±W²W¸W»WïWðWòWXX$X2X6XXXYX^X_XfXwXzX½XïÛÊ¸©›››…w›››l¸_Q_A_hÿ1\hí²6OJQJ]^Jhÿ1\hí²5OJQJ^Jhÿ1\hí²OJQJ^Jh³–OJQJ\^JhºiKhmM|OJQJ\^JhmM|OJQJ\^JhBaOJQJ\^JhºiKhBaOJQJ\^JhBaCJOJQJ\^JaJ#h—T¾h–H|CJOJQJ\^JaJ hÈ?k5CJOJQJ\^JaJ&h—T¾h–H|5CJOJQJ\^JaJ h—GÌ5CJOJQJ\^JaJ_XcXfXgXóó?³kd¿I$$If–lÖÖFt"ì&ä*t"xø Ö tàÖÿÿÿàààÿàààÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölpÖÿÿÿÿÿÿÿÿÿÿÿàààÿàààytÿ1\$$Ifa$gdÿ1\gX¾X¿XÀXÁXYYÝÈÈ:ÝÈŽkd J$$If–lÖÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\ ÆV„V„ªþ$If^„V`„ªþgdÿ1\! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\½X¾XÁXYY{Y¯Y±Y²Y[Ž[[‘[¶[·[¸[¹[Ë[Í[ò[ó[ô[õ[ü[ \2\3\4\I\ðãÔãÅ¶ÅÔã¨Ôã™Š™Š™}™Š™Š™n™}_Ph .5CJOJQJ^JaJhÝ5CJOJQJ^JaJhÿ1\h.!ÎOJQJ^JaJhÿ1\h–H|OJQJ^Jhÿ1\hBaOJQJ^JaJhÿ1\h–H|OJQJ^JaJ*hÿ1\hí²OJQJ^Jhÿ1\hYRÿOJQJ^JaJhÿ1\hí²OJQJ^JaJhÿ1\hí²OJQJ^JaJhÿ1\hí²OJQJ^Jhÿ1\hí²5OJQJ\^JYYY²Y³Y´Yê\:êê! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\Žkd6K$$If–lÖÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\ ÆV„V„ªþ$If^„V`„ªþgdÿ1\´YµYaZbZcZqO:: ÆV„V„ªþ$If^„V`„ªþgdÿ1\! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\ŽkdÌK$$If–lÖÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\cZdZ[[[oM88 ÆV„V„ªþ$If^„V`„ªþgdÿ1\! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\kdbL$$If–lÖ”ÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\[[N[Ž[[[oQ@@@$5$7$8$9DH$Ifgdÿ1\ &F ÆÐ<„0ý$5$7$8$9DH$If`„0ýgdÿ1\kdüL$$If–lÖ”-ÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\[‘[Ë[Ì[oM8 ÆV„V„ªþ$If^„V`„ªþgdÿ1\! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\kd–M$$If–lÖ”-ÖFt"ì&ä*t"xø tàÖ0ÿÿÿÿÿÿöä*6öÖÿÿÿÖÿÿÿÖÿÿÿÖÿÿÿ4Ö4Ö laölytÿ1\Ì[Í[2\•s! &F ÆÐV„V„ªþ$5$7$8$9DH$If^„V`„ªþgdÿ1\jkd0N$$If–lÖ”-Öä*ä* tàÖ0ÿÿÿÿÿÿöä*6öÖÿÖÿÖÿÖÿ4Ö4Ö laölytÿ1\2\3\4\I\°^P_~_ `Q`•Œ{rWRWRgd . &F ÆÐh„h¤5$7$8$9DH$^„hgdòAß„^„gd . &F Æ h„`ú`„`úgd—GÌ„^„gdÝjkd®N$$If–lÖ”-Öä*ä* tàÖ0ÿÿÿÿÿÿöä*6öÖÿÖÿÖÿÖÿ4Ö4Ö laölytÿ1\I\‚\°\ú\]°^_0_P_Q_R_`_a_b_j_k_y_z_{_~_Ø_÷_` `````&`'`5`6`7`9`óãóãóÕÊÕó¹ó¥¹ó¹ó‘¹óÕ†Õó¹ór¹ó¹ó^¹ó'j”Ph§$—h .OJQJU^J'jPh§$—h .OJQJU^JhU„5OJQJ^J'j¤Oh§$—h .OJQJU^J'j,Oh§$—h .OJQJU^J!jh§$—h .OJQJU^JhP²5OJQJ^Jh§$—h .5OJQJ^Jh§$—h .5OJQJ\^Jh§$—h .OJQJ^J!9`<`=`K`L`M`P`Q``Ÿ``Ç`Ì`Û`Ü`Ý`a a€aöåØÄåö·§šš€§šp_M?hª-”CJOJQJ^JaJ#jh7jëCJOJQJU^JaJ h?1¾h?1¾CJOJQJ^JaJh§$—hKR—5OJQJ\^JhP²5OJQJ\^Jh?1¾5OJQJ\^Jh .5OJQJ\^Jh§$—h .5OJQJ\^Jh§$—h .OJQJ^J'jQh§$—hYRÿOJQJU^Jh§$—hYRÿOJQJ^J!jh§$—hYRÿOJQJU^JhYRÿOJQJ^JQ`Ü`Ý`ø`bHcÁcYeZeffúúñÜÇÜÜ²¥„h$5$7$8$9DH$If^„hgd?1¾ „$If^„gd?1¾„h$5$7$8$9DH$If^„hgdò¼ &F$5$7$8$9DH$Ifgd?1¾ &F$5$7$8$9DH$Ifgd?1¾ $Ifgdjgd . €aa‚a¦a§a–b›bŸbXeYeZeoeze{ee•e–eêØÏØ¾°Ÿ¾‘€l[J[l2/jh?1¾h?1¾5CJOJQJU\^JaJ h©ó5CJOJQJ\^JaJ hZ95CJOJQJ\^JaJ&h?1¾h?1¾5CJOJQJ\^JaJ h?1¾hò¼CJOJQJ^JaJh?1¾CJOJQJ^JaJ h?1¾h@WCJOJQJ^JaJh@WCJOJQJ^JaJ h?1¾h?1¾CJOJQJ^JaJh7jëh?1¾0J#jh7jëCJOJQJU^JaJ)j„Qhª-”CJOJQJU^JaJ–eéeêeëeffffffff@fAfïÔ¼°¼œ‹}n_PA/#h—T¾h—T¾5CJOJQJ^JaJh—T¾5CJOJQJ^JaJh—GÌ5CJOJQJ^JaJhKR—5CJOJQJ^JaJhþDœ5CJOJQJ^JaJh?1¾CJOJQJ^JaJ h?1¾h?1¾CJOJQJ^JaJ&h?1¾h?1¾5CJOJQJ\^JaJh?1¾h?1¾0J5\/jh?1¾h?1¾5CJOJQJU\^JaJ5jÝRh?1¾hª-”5CJOJQJU\^JaJ hª-”5CJOJQJ\^JaJ ffffAf[fKhLhMhNhž™™™rrrrr&$d%d&d'dNÆÿOÆÿPÆÿQÆÿgdQ $gd—T¾`kdöS$$If–sÖ”cÖÿ˜+,Ö0ÿÿÿÿÿÿö,ööÖÿÖÿÖÿÖÿ4Ö saö Af”g˜g›gIhJhKhLhMhNhkh~hhhŽh·h¸hÉhÚhÛhïáïÐ¿ïá± ïáïár`N= hznàh?1¾CJOJQJ^JaJ#h†Ah?1¾>*CJOJQJ^JaJ#hznàh?1¾5CJOJQJ^JaJh?1¾5CJOJQJ^JaJhQ $h—T¾5OJQJ^J h—T¾h—T¾CJOJQJ^JaJ h—T¾høCJOJQJ^JaJhÈ?kCJOJQJ^JaJ h¾TÎhÈ?kCJOJQJ^JaJ h¾TÎh—T¾CJOJQJ^JaJh—T¾CJOJQJ^JaJ h—T¾h—T¾CJOJQJ^JaJNhŽh·hÈhËˆ$$„°&`#$*$/„´Ifa$gd?1¾- Æ,À!(#$d%d&d'dNÆÿOÆÿPÆÿQÆÿgdQ $4 Æ,À!„Ð„0ý$d%d&d'dNÆÿOÆÿPÆÿQÆÿ^„Ð`„0ýgdQ $ÈhÉhÜh†iÊiIjJjpj~kkkSCC$„°&`#$/„´Ifgd?1¾„l„†ý$„°&`#$/„´If^„l`„†ýgd?1¾dh$„°&`#$/„´Ifgd?1¾kdwT$$If–l4Ö”Ö”ÿò+^, Ö 6`”°”´Ö ÿÙÙÙÖ0ÿÿÿÿÿÿö^,ööÖÿÖÿÖÿÖÿ”´4Ö l`Ö ÿÙÙÙaöf4pÖ ÿÙÙÙÛhÜhiii#ini…i†iŠi´i·iÊiÎiIjJjKjNjQjpjqj¾jÁjkkkkHk^kdkk´kÏkÐkòáòáòÓÁáòáòáòá°òŸòŸ°áòá{jòá\áòáXhQ $hó=÷CJOJQJ^JaJ h†Ah?1¾CJOJQJ^JaJ#h†Ah?1¾>*CJOJQJ^JaJ#h†Ah?1¾>*CJOJQJ^JaJ hQ $h?1¾CJOJQJ^JaJ hQ $h?1¾CJOJQJ^JaJ#hö hö 5CJOJQJ^JaJhö CJOJQJ^JaJ hznàh?1¾CJOJQJ^JaJh?1¾CJOJQJ^JaJ!pjqjÂjkkkkGkHkÍkÎkääÌ¼¼¼¼¼¼¼$„°&`#$/„´Ifgd?1¾„l„†ý$„°&`#$/„´If^„l`„†ýgd?1¾„l„†ýdh$„°&`#$/„´If^„l`„†ýgd?1¾ ÎkÏkÐkÑkÓkÔkÕk×kØkÙkÛkÜkÝkßk~yywwwwwwwwwwgd?1¾kd0U$$If–l4Ö”JÖ”ÿò+^, Ö 6`”°”´Ö ÿÙÙÙÖ0ÿÿÿÿÿÿö^,ööÖÿÖÿÖÿÖÿ”´4Ö l`Ö ÿÙÙÙaöf4pÖ ÿÙÙÙ ÐkÑkÒkÕkÖkÙkÚkÝkÞkákïkôkõkøkúkûkükýkllll lllllllll!l"l&l'l(lüôðôðôðôðèÝÕÍÅÝÁ·±·±Á·±·¦·–ƒsbÁðÁðü hP @hÖCJOJQJ^JaJhÖ0JCJOJQJ^JaJ$hP @hÖ0JCJOJQJ^JaJhÖ0JCJOJQJ^JaJhª-”0JmHnHu hÖ0JjhÖ0JUhÖhjuCJaJhMÇCJaJh“^øCJaJhç'ehÖCJaJhÖCJaJhw8jhw8UhþDœ#ßkàkákûkükllllll l!l"l#l$l%l&l'l(lýýûýòìýýÞÍýýýýýÈýýÃgd?1¾gd¦_($ ÆÀ!ø%„h]„ha$gdû& $ ÆÀ!ø%„h]„ha$„h]„h„øÿ„&`#$=0&P/R :pÓ“BP°Ð/ °à=!°@"°@#Ð$°%°°°°ÐÐ³DÐÉêyùºÎŒ‚ªK©irb@slu.eduàÉêyùºÎŒ‚ªK©&mailto:irb@slu.edu³DÐÉêyùºÎŒ‚ªK©irb@slu.eduàÉêyùºÎŒ‚ªK©&mailto:irb@slu.eduÑDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©`https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.docyXô;H¯,‚]Ä…'c¥«ÑDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©`https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.docyXô;H¯,‚]Ä…'c¥«™$$If–!vh#vZ#v;:V–P4”f 6`”Éÿ”´ö•*ö”´5ÖZ5Ö;/Öÿ/Ö ÿÿÿÿÿÿÿÿ/Öÿ4Ö4Ö Pf4u$$If–!vh#vZ:V–P4”] 6`”Éÿ”´ö•*ö;”´5ÖZ/Öÿ4Ö4Ö Pf4ytÿ1\×$$If–!vh#v_#v¬:V–s” Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ö”´,Ö5Ö_5Ö¬4Ö4Ö spÖÿÌÿÿÿÌÿÿ×$$If–!vh#v_#v¬:V–s” Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ö”´,Ö5Ö_5Ö¬4Ö4Ö spÖÿÌÿÿÿÌÿÿð$$If–!vh#v_#v¬:V–s4” Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ö”´+Ö,Ö5Ö_5Ö¬/Öÿ4Ö4Ö sf4pÖÿÌÿÿÿÌÿÿú$$If–!vh#vC#v #v¬:V–s4” Ö`` 6`”'”´ÖÿÌÿÿÿÌÿÿÖ0ÿÿÿÿÿÿö,ö”´+Ö,Ö5ÖC5Ö 5Ö¬4Ö4Ö sf4pÖÿÌÿÿÿÌÿÿÿÿ¹$$If–!vh#v_#v¬:V–s” 6`”'”´Ö0ÿÿÿÿÿÿö,ö”´,Ö5Ö_5Ö¬4Ö4Ö spÖÿÿÿÿ§$$If–!vh#v,:V–s4”? 6`”'”´Ö0ÿÿÿÿÿÿö,ö”´,Ö5Ö,4Ö4Ö sf4pÖ ÿÿhDÿÿÿÿetDÿÿÿÿeCheck6¡$$If–!vh#vò+:V–s” Ö0ÿÿÿÿÿÿöò+ö,Ö5Öò+4Ö4Ö saögÖ9lÆ¦pÖ ÿÿ¹$$If–!vh#v'#vË:V–s” Ö0ÿÿÿÿÿÿöò+ö,Ö5Ö'5ÖË4Ö4Ö saögÖ9lÆ¦pÖÿÿÿÿÄ$$If–!vh#v'#vË:V–s4” Ö0ÿÿÿÿÿÿöò+ö+Ö,Ö5Ö'5ÖË4Ö4Ö saöf4gÖ9lÆ¦pÖÿÿÿÿÒ$$If–!vh#vœ#v‹ #vË:V–s4” Ö0ÿÿÿÿÿÿöò+ö+Ö,Ö5Öœ5Ö‹ 5ÖË4Ö4Ö saöf4pÖÿÿÿÿÿÿ·$$If–!vh#v'#vË:V–s4” Ö0ÿÿÿÿÿÿöò+ö+Ö,Ö5Ö'5ÖË4Ö4Ö saöpÖÿÿÿÿÏ$$If–!vh#vœ#v‹ #vË:V–s4” Ö0ÿÿÿÿÿÿöò+ö+Ö,Ö5Öœ5Ö‹ 5ÖË4Ö4Ö saöpÖÿÿÿÿÿÿxDÿÿÿÿeCheck141xDÿÿÿÿeCheck141xDÿÿÿÿeCheck139xDÿÿÿÿeCheck141xDÿÿÿÿeCheck133xDÿÿÿÿeCheck134xDÿÿÿÿeCheck134xDÿÿÿÿeCheck135xDÿÿÿÿeCheck136xDÿÿÿÿeCheck137xDÿÿÿÿeCheck138xDÿÿÿÿeCheck140xDÿÿÿÿeCheck135xDÿÿÿÿeCheck136²$$If–!vh#v,:V–l”3 Ö tà 6`”1”´Ö ÿæææÖ0ÿÿÿÿÿÿö,6”´5Ö,`Ö ÿæææpÖ ÿæææytÿ1\xDÿÿÿÿeCheck141xDÿÿÿÿeCheck142xDÿÿÿÿeCheck143²$$If–!vh#v,:V–l”Á Ö tà 6`”1”´Ö ÿæææÖ0ÿÿÿÿÿÿö,6”´5Ö,`Ö ÿæææpÖ ÿæææytÿ1\vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50xDÿÿÿÿeCheck135xDÿÿÿÿeCheck135xDÿÿÿÿeCheck135vDÿÿÿÿeCheck10tDÿÿÿÿeCheck8ÅDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©Thttps://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/consent_recruitment_statement_template.docyXô;H¯,‚]Ä…'c¥«tDÿÿÿÿeCheck9ûDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©xhttp://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html46.117vDÿÿÿÿeCheck17xDÿÿÿÿeCheck135©DÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©8https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_authorization_form.docyXô;H¯,‚]Ä…'c¥«xDÿÿÿÿeCheck135§DÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©6https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_waiver_alteration.docyXô;H¯,‚]Ä…'c¥«xDÿÿÿÿeCheck135ËDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©Zhttps://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/hipaa_deidentification_certification_form.docyXô;H¯,‚]Ä…'c¥«vDÿÿÿÿeCheck50ÑDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©`https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.docyXô;H¯,‚]Ä…'c¥«vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50xDÿÿÿÿeCheck152vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50ÿDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©Žhttp://www.slu.edu/research/irb/documents/postirbapprovalreporting.docvDÿÿÿÿeCheck30~$$If–‰!vh#v¸):V–l”XÖ0ÿÿÿÿÿÿö6ö5Ö¸)4Öaö‰x$$If– !vh#v+:V–l tàÖ0ÿÿÿÿÿÿö65Ö+aö ytÿ1\hDÿÿÿÿehDÿÿÿÿex$$If– !vh#v+:V–l tàÖ0ÿÿÿÿÿÿö65Ö+aö ytÿ1\ÓDÓDlu.edu/research/irb/irb_instruc.htmlvDÿÿÿÿeCheck50vDÿÿÿÿeCheck50x$$If– !vh#v+:V–l tàÖ0ÿÿÿÿÿÿö65Ö+aö ytÿ1\tDÿÿÿÿeCheck6tDÿÿÿÿeCheck6†$$If– !vh#vž%#vÞ:V–l tàÖ0ÿÿÿÿÿÿö65Öž%5ÖÞaö ytÿ1\†$$If– !vh#vž%#vÞ:V–l tàÖ0ÿÿÿÿÿÿö65Öž%5ÖÞaö ytÿ1\DÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©<https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/guidelines_subject_accrual.docyXô;H¯,‚]Ä…'c¥«”$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞ/Öÿaö ytÿ1\»$$If– !vh#vž%#vÞ:V–l Ö t¿Öÿÿÿ³³³Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö pÖÿÿÿ³³³ytÿ1\†$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö ytÿ1\$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö pÖÿÿÿÿytÿ1\$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö pÖÿÿÿÿytÿ1\«$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞ/Öÿaö pÖÿÿÿÿytÿ1\$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö pÖÿÿÿÿytÿ1\$$If– !vh#vž%#vÞ:V–l t¿Ö0ÿÿÿÿÿÿö65Öž%5ÖÞaö pÖÿÿÿÿÿÿÿÿÿÿÿÿytÿ1\|$$If–z!vh#v|):V–l”^ tàÖ0ÿÿÿÿÿÿö65Ö|)aözytÿ1\vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50x$$If–z!vh#v|):V–l tàÖ0ÿÿÿÿÿÿö65Ö|)aözytÿ1\hDÿÿÿÿehDÿÿÿÿehDÿÿÿÿeŒ$$If–!vh#v@):V–l”^ 6 ”Š””´Ö0ÿÿÿÿÿÿö6ö”´5Ö@)4ÖvDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50ÑDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©`https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/form_change-in-protocol_for_information_only.docyXô;H¯,‚]Ä…'c¥«±DÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©@https://www.slu.edu/research/faculty-resources/research-integrity-safety/institutional-review-board-irb/irb_assets/guidelines_reportable_events.docyXô;H¯,‚]Ä…'c¥«Š$$If–l!vh#v$#vx:V–l”Ó tàÖ0ÿÿÿÿÿÿö+65Ö$5Öxaölytÿ1\Š$$If–l!vh#v$#vx:V–l”Ó tàÖ0ÿÿÿÿÿÿö+65Ö$5Öxaölytÿ1\vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50vDÿÿÿÿeCheck50Œ$$If–!vh#v@):V–l”^ 6 ”Š””´Ö0ÿÿÿÿÿÿö6ö”´5Ö@)4Öß$$If–l!vh#vt"#vx#vø:V–l Ö tàÖÿÿÿàààÿàààÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5ÖøaölpÖÿÿÿÿÿÿÿÿÿÿÿàààÿàààytÿ1\”$$If–l!vh#vt"#vx#vø:V–l tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\”$$If–l!vh#vt"#vx#vø:V–l tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\”$$If–l!vh#vt"#vx#vø:V–l tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\˜$$If–l!vh#vt"#vx#vø:V–l” tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\˜$$If–l!vh#vt"#vx#vø:V–l”- tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\˜$$If–l!vh#vt"#vx#vø:V–l”- tàÖ0ÿÿÿÿÿÿöä*65Öt"5Öx5Öøaölytÿ1\|$$If–l!vh#vä*:V–l”- tàÖ0ÿÿÿÿÿÿöä*65Öä*aölytÿ1\|$$If–l!vh#vä*:V–l”- tàÖ0ÿÿÿÿÿÿöä*65Öä*aölytÿ1\xDÿÿÿÿeCheck148xDÿÿÿÿeCheck149xDÿÿÿÿeCheck150xDÿÿÿÿeCheck151xDÿÿÿÿeCheck151YDÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©èhttps://www.slu.edu/research/faculty-resources/research-integrity-safety/conflict-of-interest-coirc.phpyXô;H¯,‚]Ä…'c¥«DÐÉêyùºÎŒ‚ªK©àÉêyùºÎŒ‚ªK©¨https://www.slu.edu/general-counsel/compliance/conflict-of-interest.phpyXô;H¯,‚]Ä…'c¥«$$If–!vh#v,:V–s”cÖ0ÿÿÿÿÿÿö,ö5Ö,4Ö4Ö s·$$If–!vh#v^,:V–l4” Ö 6`”°”´Ö ÿÙÙÙÖ0ÿÿÿÿÿÿö^,ö”´5Ö^,4Ö`Ö ÿÙÙÙf4pÖ ÿÙÙÙ½$$If–!vh#v^,:V–l4”J Ö 6`”°”´Ö ÿÙÙÙÖ0ÿÿÿÿÿÿö^,ö”´,Ö5Ö^,4Ö`Ö ÿÙÙÙf4pÖ ÿÙÙÙ^$2ÀÐàð 0@P`p€ÀÐàð2(Øè 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€8XøV~_HmH nH sH tH H`ñÿHNormal5$7$8$9DH$_HmH sH tH <@< Heading 1$@&5CJ>@> Heading 2$$@&a$5Z@Z Heading 3$$&d@&PÆÿa$ 6CJ\]T@T Heading 4$$@&a$5CJOJQJ\^JaJ$T@T Heading 5$$*$@&a$5OJQJ\^JaJ^@^ Heading 6$$5$9D@&H$a$5CJOJQJ\^JaJR@RL5¢ Heading 7¤ð¤<5$7$8$9D@&H$CJaJDA`òÿ¡DDefault Paragraph FontVi@óÿ³VTable Normal :Vö4Ö4Ö laö(k ôÿÁ(No List2B@ò2 Body Text56P@6Body Text 2CJ4>@4Title$a$5CJ4@"4Header ÆàÀ!4 @24Footer ÆàÀ!.)@¢A.Page NumberR+@RREndnote Text1$5$9DH$CJOJQJaJNU`òÿaN Hyperlink#>*B*CJOJQJ^JaJo(ph™H™@rHBalloon TextCJOJQJ^JaJzš³ƒz Table Grid7:VÖ0ÿÿÿÿÿÿ5$7$8$9DH$n^@’nNormal (Web)(„á¤d¤d5$7$8$9DH$[$\$]„áCJOJQJ^JaJFV`òÿ¡FFollowedHyperlink>*B*ph€€8þO²8 pt1dð1$5$9DCJaJHC@ÂHrK¦Body Text Indent„h¤x^„h:þOÒ: &t11dð1$5$9DCJaJRRâRL5¢Body Text Indent 2„hdà¤x^„h@þOò@—T¾c10$dð1$5$9Da$CJaJB'`òÿBi3ŸComment ReferenceCJaJ4@4i3ŸComment Text!@j@@i3ŸComment Subject"5\RY@2Rí²Document Map#-D MÆ ÿ€OJQJ^JPK!éÞ¿ÿ[Content_Types].xml¬‘ËNÃ0E÷Hüƒå-Jœ²@%é‚ÇŽÇ¢|ÀÈ™$ÉØ²§Uû÷LÒTB¨ l,Ù3÷ž;ãr½µÃ˜œ§J¯òB+$ëG]¥ß7OÙV‰$ùãûÿ©«×îÇ!)OÚ^ýrÍC$ñy@“°íÝö/yH*œ˜ñ„´½)‘Þµ÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ©OÐP“ô6râ=¯‰’zÀgb Ig…ÁuSÙebÖö€OÀ†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0÷+[}`j×ëõº½zAÏ°ïƒ¦V–2ÍFÞÉi–@öqžv·Ö¬5\|‰þÊœÌN§Óle²X¢dsøµÚjcsÙÁÅ7çðÎf·»êà ÈâWçðý+Õ†‹7 ˆÑä`ÚïgÔÈ˜³íJøÀ×j|†‚h(¢K³óD-Šµßã¢ dXÑ©iJÆØ‡(îâx$(Öð:Á¥;äË¹!ÍI_ÐTµ½S1£÷êù÷¯ž?EÇž?øéøáÃã?ZBÎªmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&Î‹/ŸüöìÉ‹¯>ýý»GðMGeøÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:Äµàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€ íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i~™Véþvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘â˜• ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*Ý¾Ë¦±‹ŠTÑ¼9/#·øA7ÂqZ…Ð$*c?¢íqUßån†èwðNºû%Ž»O¯·ièˆ4=3¾¼N¸¿ƒ)cbJ u§VÇ4ù»ÂÍ(TnËáâ 7”Ê_?®ûm-Ù›°{UåÌö‰B½w²ÒzÏû¨nœ”ÇÊœ"ZúàxŠÕJÜZšìp;‹“ÊìØåÞ{/å<óP;™Ž,)''KÐQÛk5—›òqÚöÆpN†Ç8¯KÝGbÂe“¯„ ûS“ÙdùÌ›\17 êpõaí>§°SR!Õ–‘ 3•…K4'+ÿrÌzQ TT£³I±²Áð¯Ivt]KÆcâ«²³K#Úvö5+¥|¢ˆDÁ±‰ØÇà~ª O@%\w˜Š _ànN[ÛL¹Å9Kºò˜ÁÙqÌÒgåV§hžÉn R!ƒy+‰ºUÊn”;¿*&å/H•rÿÏTÑû Ü>¬Ú>\ Œt¦´=.TÄ¡ ¥õûS; Zà~¦!¨à‚ÚüäPÿ·9gi˜´†C¤Ú§!ö# Bö ,™è;…X=Û»,I–2UW¦Vì9$l¨kàªÞÛ=A¨›j’•ƒ;î{–A£P79å|s*Y±÷Úø§;›Ì ”[‡MC“Û¿±hf»ª]o–ç{oY=1k³yV³ÒVÐÊÒþ5E8çVk+ÖœÆËÍ\8ðâ¼Æ0X4D)Ü!!ýö?*|f¿vè uÈ÷¡¶"øx¡‰AØ@T_²ÒÒŽ q²ƒ6˜4)kÚ¬uÒVË7ëît¾'Œ%;‹¿Ïiì¢9sÙ9¹x‘ÆÎ,ìØÚŽ-45xödŠÂÐ8?ÈÇ˜Ïdå/Y|t½ß&LILðJ`è¡& ù-G³tã/ÿÿPK! ÑŸ¶'theme/theme/_rels/themeManager.xml.rels„M Â0„÷‚wooÓº‘&ÝˆÐÔ„ä5 6?$Qìí ®,.‡a¾™i»—Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!éÞ¿ÿ[Content_Types].xmlPK-!¥Ö§çÀ60_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!0ÝC)¨¤Ötheme/theme/theme1.xmlPK-! ÑŸ¶'² theme/theme/_rels/themeManager.xml.relsPK] (dÿÿÿÿ3ÿÿÿÿ4ÿÿÿÿÿÿÿÿÿÿ(dtÿÿÿÿ+7PPPS• Ñø({ å©ó* Ã!j"#Ä#(‹)*°*+à,§./(2†3ú3»4Y6Ÿ7ú8Ü93<ð<Ž> ?µ÷´¡ßAÄB°¶Ù±··¡´Ç¹ó‚GÍI!°³¢ÊLÎMñN)±ÊÈQ$¸éˆSäT³Õ»ß•W½X±õ°À9¸¿¶Ä²¹–e´¡´ÚÛhÐk(±ô79:;<>?°ª´¡µþ¶Ù´³²Ñ°Õ³Õ°Â³Ý³Û´Ü°À³å¸¿²¹²ú³¦±ð²µ³óÂá°ì±ô³¾²Ô´Ç±è°ù²õ³Ü·É²â³ú´¥°¨¶Ä…‰‘’”•—˜™šžŸ¡¤¬¯°²µ¸„ž°Õ²Úò&…ü"¶Ù³Ýƒ—#$(ß+²ú-ˆ0Á8Þ<g>™?ÜACJDfEFhFÄFûFG,IIÌIžJEKÍMKO0TàTbW_XgXY´YcZ[[Ì[2\Q`fNhÈhpjÎkßk(l8=CEFGHIKLNOPQRSU[]^dfiqtvx{~‚ƒ„†‡ˆŠ‹ŒŽ“–›œ ¢£¥¦§¨©ª«®±³´¶·¹)5•·ÃZ #>V¯¿Öæšª ZjÐà+u…ÑáÆÖáñ@P[ksƒÙéôk{ÉÙ„”Ø!è!;"K"¡"±" ##Ž#ž#ß#ï#;$K$%%b%r%t%&?&A&Q&S&¨&Å&Ç&×&m'}'—'4(M(ˆ(˜(š(6)g)i)y){))*T*Å*Õ*Ö*‡+Ÿ+¢+²+ë+û+,,<,œ.¬.f/v/Z0j0Á0Ñ0Ë1Û133Ë3Û334‡44¯4¿4Ž6ž6¤6´6"8b8z8{9‹99 9”:¤:Ã:Ó:h<=!=ðBCCCDDD/DˆD˜DÈFØFßFïFH"H)H9HÑH‚I•I|JKZKpN€NŠNšNìNüNQWaWjWzW XX&X6X@S!•!ÿ•€ð@ð 55@ñÿÿÿ€€€÷ðNð4ðìð( ð ððV¢ ð3 #ð€Š3"ñ?ðð ððV¢ ð4 #ð€Š4"ñ?ðð ððB ðSð¿Ëÿ ?ðð4[5(d3%&ÿÿÿÅ+t4%&Å+÷tÿÿR _Hlt205105143 _Hlt205105144 _Hlt205105147 _Hlt205105148 OLE_LINK1Check141Check133Check134Check135Check136Check137Check138Check142Check143Check10 _Hlt205105157 _Hlt205105158Check8 _Hlt104014084_Hlt62439995 _Hlt205105160 _Hlt205105161 _Hlt104014516_Hlt62439795Check9 _Hlt104014524 _Hlt104014525_Hlt62439810_Hlt62439811 _Hlt104019735 _Hlt104019736 _Hlt104014104 _Hlt104020422 _Hlt104020423 _Hlt104014092 _Hlt104014093 _Hlt104020484 _Hlt104020485_Hlt62439821 _Hlt285717811 _Hlt285717812_Hlt62439999_Hlt62440000 _Hlt285717030 _Hlt285717031Check17 _Hlt205105175 _Hlt205105176 _Hlt205105178 _Hlt205105179 _Hlt205105182 _Hlt205105183 _Hlt205105185 _Hlt205105186Check152 _Hlt147038470 _Hlt147038253 _Hlt147038254 _Hlt147038271 OLE_LINK4Check30 _Hlt205105191_Hlt23925029_Hlt23925030Check6 _Hlt205105231 evaluable _Hlt205105242 _Hlt205105243 _Hlt205105247 _Hlt205105248Check148Check149Check150Check151 _Hlt285717851 _Hlt285717828 _Hlt205105258 _Hlt205105259 _Hlt205105262 _Hlt205105263 _Hlt285717858JJ×ÑuÆß@YÅ€%E%E%c%.&5&9&9&:&=&B&³&³&·&·&¸&¸&¹&º&º&¼&¼&¼&¼&½&¿&¿&À&À&Â&Â&È&D(D(b)b)H*H*—+—+Â04“4“4“4¯4°4d8k8k8•:=}@’I’IDKDKQWjW X&X”Y™YYY÷]÷]ú])d@@@@ @@@@@@@@@@@@@@@ @!@"@#@$@%@&@'@(@)@*@+@,@-.@/@0@1@2@3@4@5@67@8@9@:@;<=@>@?@@A@BC@D@E@F@GHIJK@L@M@N@O@P@Q@KKUá,â×òQlÚ•%F%F%s%/&6&:&:&;&>&R&´&´&¸&¸&¹&¹&º&»&»&½&½&½&½&¾&À&À&Á&Á&Ã&Ã&Ø&E(E(c)c)I*I*˜+˜+Ò04”4”4”4À4À4e8l8l8¥:=}@“I“IEKEKbW{WX7X•YšYžYžYø]ø]û])dÿÿ(•)•*•+•,•-•.•/•0•1•2•3•4•5•6•7•8•9•:•;• rr~××ã+llxîI2J7JM·M½O)d ¤}ˆˆâíí.w‚‚ñI5J:J MºMÁO)d =*€urn:schemas-microsoft-com:office:smarttags €PlaceType€=*€urn:schemas-microsoft-com:office:smarttags €PlaceName€9*€urn:schemas-microsoft-com:office:smarttags€place€?*€urn:schemas-microsoft-com:office:smarttags€stockticker€BöM [ 1€Ž>²Ï¸é»å%%%%%(%³å%³å%²ú%³Ü%&+&,&?&'˜'4(:(;(¸é(ˆ(›(6)<)=)Q)i)|))*/*0*T*Å*×*‡+š+›+Ÿ+\<i<===!=ÄHÒH‚I‰IŠI›IpJ|J[K\KmK YY–]ê]ÐcÑcÑcÔcÕcÕcØcÙcÜcÝcàcácøcøcücddd!d)d…ˆ5"9"" " ##µ&Á&=,,0“0N1U1'5-5˜5š5½9Æ9Ô:Ú:°CµC½CÄCŒQ”QÑcÔcÕcØcÙcÜcÝcàcác!d"d&d)d3333333333333339:xx‹Œ,,· Ð ì í î î û '((+>@A––——[ <Ž>Ñí×ö0>STUVŽ'ý˜Äó>…×Ù, ´#$%%_%_%u%&S&Æ&'—'˜'4(S(S(†(†(›(6)i)|))*W*×*‡+Á0Á0ø0¡1¯4ð4C6i6Þ9ð9;=;i<=O=f=ö=>é@ÍA›B›BÕDÕD4ELEZE[E[EdEgEoEÊEÒH‚I¾I¿I|J[KNNROeOeOfOfOgO“O”O”O•O>PgP"TITQW~WÝXøXY§Y[Á[–]ê]^^N`É`ÏcÐcÑcÑcÔcÕcÕcØcÙcÜcÝcàcácôcõcøcúcdd!d)d9:xx‹Œ[ Ž>ö>³§°Õ±«%%³å%³å%³Ü%&˜'4(›(6)´¥))*×*‡+¾±<=ÒH‚I|J[K YY–]ê]ÐcÑcÑcÔcÕcÕcØcÙcÜcÝcàcácøcúc!d"d)dþÿÿÿÿÿÿÿÿ2®`»šNÿÿÿÿÿÿÿÿÿ! TbDŠàžÿÿÿÿÿÿÿÿÿj3³b€Å~žÿÿÿÿÿÿÿÿÿMLih¢Íÿÿÿÿÿÿÿÿÿ’^WnŠÑ¡ÿÿÿÿÿÿÿÿÿ]1sx×žÿÿÿÿÿÿÿÿÿRn.wX•Ïÿÿÿÿÿÿÿÿÿ ÁwPÚõÿÿÿÿÿÿÿÿÿKy<ã¬†ÿÿÿÿÿÿÿÿÿs#ç{fu ^ÿÿÿÿÿÿÿÿÿ*„Ð„˜þÆÐ^„Ð`„˜þo(.h„ „˜þÆ ^„ `„˜þOJQJo(·ð‚„p„LÿÆp^„p`„Lÿ.€„@„˜þÆ@^„@`„˜þ.€„„˜þÆ^„`„˜þ.‚„à„LÿÆà^„à`„Lÿ.€„°„˜þÆ°^„°`„˜þ.€„€„˜þÆ€^„€`„˜þ.‚„P„LÿÆP^„P`„Lÿ.h„Ð„˜þÆÐ^„Ð`„˜þ56o(‡hˆH.„ „˜þÆ ^„ `„˜þo(.’h „p„LÿÆp^„p`„Lÿ‡hˆH.h „@„˜þÆ@^„@`„˜þ‡hˆH.h „„˜þÆ^„`„˜þ‡hˆH.’h „à„LÿÆà^„à`„Lÿ‡hˆH.h „°„˜þÆ°^„°`„˜þ‡hˆH.h „€„˜þÆ€^„€`„˜þ‡hˆH.’h „P„LÿÆP^„P`„Lÿ‡hˆH.h„Ð„˜þÆÐ^„Ð`„˜þ56B*o(phÿ‡hˆH. „ „˜þÆ ^„ `„˜þ‡hˆH.‚ „p„LÿÆp^„p`„Lÿ‡hˆH.€ „@„˜þÆ@^„@`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „à„LÿÆà^„à`„Lÿ‡hˆH.€ „°„˜þÆ°^„°`„˜þ‡hˆH.€ „€„˜þÆ€^„€`„˜þ‡hˆH.‚ „P„LÿÆP^„P`„Lÿ‡hˆH.8„8„˜þÆ8^„8`„˜þOJQJo(‡hˆHØð8„8„˜þÆ8^„8`„˜þOJQJ^Jo(‡hˆHo8„„˜þÆ^„`„˜þOJQJo(‡hˆH§ð8„Ø „˜þÆØ ^„Ø `„˜þOJQJo(‡hˆH·ð8„¨„˜þÆ¨^„¨`„˜þOJQJ^Jo(‡hˆHo8„x„˜þÆx^„x`„˜þOJQJo(‡hˆH§ð8„H„˜þÆH^„H`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„è„˜þÆè^„è`„˜þOJQJo(‡hˆH§ð8„ „˜þÆ ^„ `„˜þOJQJo(‡hˆHØð8„ „˜þÆ ^„ `„˜þOJQJo(‡hˆH·ð8„p„˜þÆp^„p`„˜þOJQJo(‡hˆH·ð8„@„˜þÆ@^„@`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„à„˜þÆà^„à`„˜þOJQJo(‡hˆH§ð8„°„˜þÆ°^„°`„˜þOJQJo(‡hˆH·ð8„€„˜þÆ€^„€`„˜þOJQJ^Jo(‡hˆHo8„P„˜þÆP^„P`„˜þOJQJo(‡hˆH§ðh „®„˜þÆ®^„®`„˜þ‡hˆH.h „~ „˜þÆ~ ^„~ `„˜þ‡hˆH.h „N„LÿÆN^„N`„Lÿ‡hˆH.h „„˜þÆ^„`„˜þ‡hˆH.h „î„˜þÆî^„î`„˜þ‡hˆH.h „¾„LÿÆ¾^„¾`„Lÿ‡hˆH.h „Ž„˜þÆŽ^„Ž`„˜þ‡hˆH.h „^„˜þÆ^^„^`„˜þ‡hˆH.h „.„LÿÆ.^„.`„Lÿ‡hˆH.h „Â„˜þÆÂ^„Â`„˜þ5‡hˆH.h „ „˜þÆ ^„ `„˜þ‡hˆH.’h „p„LÿÆp^„p`„Lÿ‡hˆH.h „@„˜þÆ@^„@`„˜þ‡hˆH.h „„˜þÆ^„`„˜þ‡hˆH.’h „à„LÿÆà^„à`„Lÿ‡hˆH.h „°„˜þÆ°^„°`„˜þ‡hˆH.h „€„˜þÆ€^„€`„˜þ‡hˆH.’h „P„LÿÆP^„P`„Lÿ‡hˆH.h „v„˜þÆv^„v`„˜þ‡hˆH.h „F„˜þÆF^„F`„˜þ‡hˆH.’h „„LÿÆ^„`„Lÿ‡hˆH.h „æ „˜þÆæ ^„æ `„˜þ‡hˆH.h „¶ „˜þÆ¶ ^„¶ `„˜þ‡hˆH.’h „†„LÿÆ†^„†`„Lÿ‡hˆH.h „V„˜þÆV^„V`„˜þ‡hˆH.h „&„˜þÆ&^„&`„˜þ‡hˆH.’h „ö„LÿÆö^„ö`„Lÿ‡hˆH.„Ð„˜þÆÐ^„Ð`„˜þ56o(‡hˆH.„ „˜þÆ ^„ `„˜þ5o(.‚ „p„LÿÆp^„p`„Lÿ‡hˆH.€ „@„˜þÆ@^„@`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „à„LÿÆà^„à`„Lÿ‡hˆH.€ „°„˜þÆ°^„°`„˜þ‡hˆH.€ „€„˜þÆ€^„€`„˜þ‡hˆH.‚ „P„LÿÆP^„P`„Lÿ‡hˆH.8„8„˜þÆ8^„8`„˜þOJQJo(‡hˆHØð8„8„˜þÆ8^„8`„˜þOJQJ^Jo(‡hˆHo8„„˜þÆ^„`„˜þOJQJo(‡hˆH§ð8„Ø „˜þÆØ ^„Ø `„˜þOJQJo(‡hˆH·ð8„¨„˜þÆ¨^„¨`„˜þOJQJ^Jo(‡hˆHo8„x„˜þÆx^„x`„˜þOJQJo(‡hˆH§ð8„H„˜þÆH^„H`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„è„˜þÆè^„è`„˜þOJQJo(‡hˆH§ð„h„˜þÆh^„h`„˜þ6o(.€ „8„˜þÆ8^„8`„˜þ‡hˆH.‚ „„LÿÆ^„`„Lÿ‡hˆH.€ „Ø „˜þÆØ ^„Ø `„˜þ‡hˆH.€ „¨„˜þÆ¨^„¨`„˜þ‡hˆH.‚ „x„LÿÆx^„x`„Lÿ‡hˆH.€ „H„˜þÆH^„H`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „è„LÿÆè^„è`„Lÿ‡hˆH. „®„˜þÆ®^„®`„˜þo(‡hˆH.€ „ „˜þÆ ^„ `„˜þ‡hˆH.‚ „p„LÿÆp^„p`„Lÿ‡hˆH.€ „@„˜þÆ@^„@`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „à„LÿÆà^„à`„Lÿ‡hˆH.€ „°„˜þÆ°^„°`„˜þ‡hˆH.€ „€„˜þÆ€^„€`„˜þ‡hˆH.‚ „P„LÿÆP^„P`„Lÿ‡hˆH.„Ð„˜þÆÐ^„Ð`„˜þ56o(‡hˆH.€ „ „˜þÆ ^„ `„˜þ‡hˆH.‚ „p„LÿÆp^„p`„Lÿ‡hˆH.€ „@„˜þÆ@^„@`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „à„LÿÆà^„à`„Lÿ‡hˆH.€ „°„˜þÆ°^„°`„˜þ‡hˆH.€ „€„˜þÆ€^„€`„˜þ‡hˆH.‚ „P„LÿÆP^„P`„Lÿ‡hˆH.h „Ð„˜þÆÐ^„Ð`„˜þ‡hˆH.h„ „˜þÆ ^„ `„˜þ.h„p„LÿÆp^„p`„Lÿ.h„@„˜þÆ@^„@`„˜þ.h„„˜þÆ^„`„˜þ.’h„à„LÿÆà^„à`„Lÿ.h„°„˜þÆ°^„°`„˜þ.h„€„˜þÆ€^„€`„˜þ.’h„P„LÿÆP^„P`„Lÿ.h „Ð„˜þÆÐ^„Ð`„˜þ5‡hˆH.h „ „˜þÆ ^„ `„˜þ‡hˆH.’h „p„LÿÆp^„p`„Lÿ‡hˆH.h „@„˜þÆ@^„@`„˜þ‡hˆH.h „„˜þÆ^„`„˜þ‡hˆH.’h „à„LÿÆà^„à`„Lÿ‡hˆH.h „°„˜þÆ°^„°`„˜þ‡hˆH.h „€„˜þÆ€^„€`„˜þ‡hˆH.’h „P„LÿÆP^„P`„Lÿ‡hˆH.8„8„˜þÆ8^„8`„˜þB*OJQJo(phÿ‡hˆH¨ð8„8„˜þÆ8^„8`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJo(‡hˆH·ð8„Ø „˜þÆØ ^„Ø `„˜þOJQJo(‡hˆH·ð8„¨„˜þÆ¨^„¨`„˜þOJQJ^Jo(‡hˆHo8„x„˜þÆx^„x`„˜þOJQJo(‡hˆH§ð8„H„˜þÆH^„H`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„è„˜þÆè^„è`„˜þOJQJo(‡hˆH§ð8„ „˜þÆ ^„ `„˜þOJQJo(‡hˆHØð8„ „˜þÆ ^„ `„˜þOJQJo(‡hˆH·ð8„p„˜þÆp^„p`„˜þOJQJo(‡hˆH·ð8„@„˜þÆ@^„@`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„à„˜þÆà^„à`„˜þOJQJo(‡hˆH§ð8„°„˜þÆ°^„°`„˜þOJQJo(‡hˆH·ð8„€„˜þÆ€^„€`„˜þOJQJ^Jo(‡hˆHo8„P„˜þÆP^„P`„˜þOJQJo(‡hˆH§ðh „*„˜þÆ*^„*`„˜þ‡hˆH.„ „˜þÆ ^„ `„˜þo(.’h „p„LÿÆp^„p`„Lÿ‡hˆH.h „@„˜þÆ@^„@`„˜þ‡hˆH.h „„˜þÆ^„`„˜þ‡hˆH.’h „à„LÿÆà^„à`„Lÿ‡hˆH.h „°„˜þÆ°^„°`„˜þ‡hˆH.h „€„˜þÆ€^„€`„˜þ‡hˆH.’h „P„LÿÆP^„P`„Lÿ‡hˆH.„Ð„˜þÆÐ^„Ð`„˜þo(.„ „˜þÆ ^„ `„˜þo(.‚ „p„LÿÆp^„p`„Lÿ‡hˆH.€ „@„˜þÆ@^„@`„˜þ‡hˆH.€ „„˜þÆ^„`„˜þ‡hˆH.‚ „à„LÿÆà^„à`„Lÿ‡hˆH.€ „°„˜þÆ°^„°`„˜þ‡hˆH.€ „€„˜þÆ€^„€`„˜þ‡hˆH.‚ „P„LÿÆP^„P`„Lÿ‡hˆH.8„ „˜þÆ ^„ `„˜þOJQJo(‡hˆHØð8„ „˜þÆ ^„ `„˜þOJQJ^Jo(‡hˆHo8„p„˜þÆp^„p`„˜þOJQJo(‡hˆH§ð8„@„˜þÆ@^„@`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„à„˜þÆà^„à`„˜þOJQJo(‡hˆH§ð8„°„˜þÆ°^„°`„˜þOJQJo(‡hˆH·ð8„€„˜þÆ€^„€`„˜þOJQJ^Jo(‡hˆHo8„P„˜þÆP^„P`„˜þOJQJo(‡hˆH§ð8„8„˜þÆ8^„8`„˜þB*OJQJo(phÿ‡hˆH¨ð8„8„˜þÆ8^„8`„˜þOJQJ^Jo(‡hˆHo8„„˜þÆ^„`„˜þOJQJo(‡hˆH§ð8„Ø „˜þÆØ ^„Ø `„˜þOJQJo(‡hˆH·ð8„¨„˜þÆ¨^„¨`„˜þOJQJ^Jo(‡hˆHo8„x„˜þÆx^„x`„˜þOJQJo(‡hˆH§ð8„H„˜þÆH^„H`„˜þOJQJo(‡hˆH·ð8„„˜þÆ^„`„˜þOJQJ^Jo(‡hˆHo8„è„˜þÆè^„è`„˜þOJQJo(‡hˆH§ðKy]1sš04[¸Xj3³b|8f#2®`1ó\ZD‘*s#ç{ª0è%“-’^WnÊÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿàJ† @h„h„˜þ^„h`„˜þOJQJo(·ðÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ ÒóÐ ñšþ jLÌ J]U Š¥¦‰àó ,?Ÿ È$¢£ x-y9yÑ\yÕVzz{ù|–H|mM|·*€5€žR€âR€R ‚›‚¡B‚ôl‚W~‚U„d… …!6…azˆÕS‰@ ŠÙŠ«‹NŒ|sŒYNîw8ÜS?F’ºY’Z’ñ“Ó“ä;“jL“ª-”·@”£z”¼X•ìo•³–»Z–§$—Æ6—KR—dY—…_—¯{—eU˜%)™îk™È/šçIš#œþDœÖõ žøžE'Ÿi3Ÿ“wŸ‚ ±* Q ðX ¡H,¡è8¡L5¢ÄN¢¡X¢F£¥†¦rK¦×$§©¥ª|/ªËuªu&«D*¬³C¬PJ¬¥\¬JH®oQ®DT®(¯«y¯°[°µ{°`,±í².²P²]\²ey²û~³) ´Ê´¼{´T_µƒ¶-/¶ë"¸“r¹sy¹?º 2»ò¼ý½?1¾—T¾6U¿Ã"À¦,ÁÙ/Â50Â7(ÃR@Ã‘~ÄÛÆ²\Æ¹yÆ•+ÇMÇ"TÇà ÉÇPÉ0ÊºuÊ}jË—GÌeÌPÍ'aÍ.!Î\<Î¾TÎÉÏAÏbfÏäPÐé Ñ 6Ñ4DÑ4fÒH|Ò¨$ÓyÓžxÔê5Õ¦^Õ&&×ŸR×òk×O1Ùí)Úp:Ú?ÚŸkÛÙ-ÝÝzßÉßòAßàznàngá•{á½cãfäWQäŠvå¸>æ]AçáGç¹@é"ê7jëÞë-Wìô[ì eìlìÇEí®cí!î™<îú?îŸ;ï®mïö#ðÄ"ñdñïWò©ó`:óëPó7ró÷ó=÷O`÷øø“^øÿrø±ùòùú¸KúÙûJgû)üÅ ü¬7ü`ü~sþ…ÿYRÿÑcÓcÿ@ €§Y§Y§Y§Y(dà@ÿÿUnknowngibbonsmÿÿÿÿÿÿÿÿÿÿÿÿ Gÿ*àAxÀ ÿTimes New Roman5€Symbol3.ÿ*àCxÀ ÿArial71 Courier3ÿ*àAxÀ ÿTimes5.ÿ.á[`À)ÿTahoma;€Wingdings?= ÿ*àCxÀ ÿCourier NewAÿàÿ$BŸCambria Math ˆÐäk$ìâ''øÛfgâÇfåìT3µåìT3µ!„¥Àxx€24žcžc3ƒq„ÿßÿýHPðÿ?äÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿä;“2!xx ÜÿÿSaint Louis UniversityRobert O. Webster, Ph. D.mbresna1 (2nd edits)d þÿà…ŸòùOh«‘+'³Ù0Ä˜ ÀÌðü( HT t€Œ ˜¤¬´¼ä¶¶ÒõproRobert O. Webster, Ph. D.All links fixed.Normalmbresna1 (2nd edits)3Microsoft Office Word@ @ÌDnaÜÈ@Hµ!ƒªÏ@°¤@YÔåìTþÿÕÍÕœ.“—+,ù®0hp˜ ¨°¸ÀÈ Ðóä¶¶Òõproµ3žc¶¶ÒõproTitle !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~€‚ƒ„…†‡ˆ‰Š‹ŒŽ‘’“”•–—˜™š›œžŸ ¡¢£¤¥¦§¨©ª«¬®¯°±²³´µ¶·¸¹ºþÿÿÿ¼½¾¿ÀÁÂÃÄÅÆÇÈÉÊËÌÍÎÏÐÑÒÓÔÕÖ×ØÙÚÛÜÝÞßàáâãäåþÿÿÿçèéêëìíîïðñòóôõö÷øùúûüýþÿ !"#$%&'()þÿÿÿ+,-./01þÿÿÿ3456789þÿÿÿýÿÿÿýÿÿÿýÿÿÿ>þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFðkBYÔ@€Data ÿÿÿÿÿÿÿÿÿÿÿÿ»ïU1Tableÿÿÿÿæê‡WordDocumentÿÿÿÿ?tSummaryInformation(ÿÿÿÿÿÿÿÿÿÿÿÿ*DocumentSummaryInformation8ÿÿÿÿÿÿÿÿ2CompObjÿÿÿÿÿÿÿÿÿÿÿÿrÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF Microsoft Word 97-2003 Document MSWordDocWord.Document.8ô9²q